Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions: WHO TobLabNet official method SOP 09

WHO TobLabNet Official Method SOP 09 Standard Operating prOcedure fOr determinatiOn Of VOlatile OrganicS in mainStream cigarette SmOke under iSO and intenSe SmOking cOnditiOnS Tobacco Free Initiative Tobacco Laboratory Network (TobLabNet) World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3 WHO TobLabNet Official Method SOP 09 Standard operating pr cedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 4 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Standard operating procedure for etermination of volatile organics in ainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09 ISBN 978-92-4-151477-4 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine w ther permission is needed for that reuse a d to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Printed in Switzerland World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 5 No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: Benzene (CAS# 71-43-2) 1,3-butadiene (CAS# 106-99-0) Matrix: Tobacc cigarette mainstream smoke particulate matter Last update: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 6 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions No machine smoking regimen an represent all human smoking behaviour: machine smoking testing is useful for characterizing cigarette emissions for des gn and regulatory purp ses, but communication of machine measurements to smokers can result in misunderstanding about differ nces b tween brands in exposure and risk. Data on smoke emissions from machine measurements may be used as inputs for product hazard assessment, but they are not intended to be nor are they valid as measur of human exposure or risks. Representing differences in machine measurements as differences in exposure or risk is a misuse of testing w th WHO TobLabNet standards. No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 7 FOREWORD This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for measuring volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions. INTRODUCTION In order to establish comparable measurements for testing tobacco products globally, consensus methods are required for measuring specific contents and emissions of cigarettes. The Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (WHO FCTC) at its third session in Durban, South Africa, in November 2008, recalling its decisions FCTC/COP1(15) and FCTC/COP2(14) on the elaboration of guidelines for implementation of Articles 9 (Regulation of the contents of tobacco products) and 10 (Regulation of tobacco product disclosures) of the WHO FCTC, noting the information contained in the report of the working group to the third session of the Conference of the Parties on the progress of its work … requested the Convention Secretariat to invite WHO’s Tobacco Free Initiative to “validate, within five years, the analytical chemical methods for testing and measuring cigarette contents and emissions”.1 Using the criteria for prioritization set at its third meeting in Ottawa, Canada, in October 2006, the working group on Articles 9 and 10 identified the following contents for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • nicotine • ammonia • humectants (propane-1,2-diol, glycerol (propane-1,2,3-triol) and triethylene glycol (2,2-ethylenedioxybis(ethanol)). Measurement of these contents will require validation of three methods: one for nicotine, one for ammonia and one for humectants. Using the criteria for prioritiz ti set at the meeting i Ottawa m ntioned above, the working group ident fied the following emissions in mainstream smoke for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) • N-nitrosonornicotine (NNN) 1 Decision, third session of the Conference of the Parties to the WHO FCTC; 2008 (http://apps.who. int/gb/fctc/PDF/cop3/FCTC_COP3_REC1- n.pdf). No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 8 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions • acetaldehyde • acrylaldehyde (acrolein) • benzene • benzo[a]pyrene • 1,3-butadiene • carbon monoxide • formaldehyde Measurement of these emissions with the two smoking r gimens described below will require validation of four methods: one for tobacco-specific nitrosamines (NNK and NNN), one for benzo[a]pyrene, one for aldehydes (acetaldehyde, acrolein and formaldehyde), one for volatile organic compounds (benzene, 1,3-butadiene) and one for carbon monoxide. The table below sets out the two smoking regimens for validation of the test methods referred to above. Smoking regimen Puff volume (mL) Puff frequency Filter ventilation holes ISO regimen: ISO 3308; Routine analytical cigarette smoking machine—definitions and standard conditions 35 Once every 60 s No modifications Intense regimen: Same as ISO 3308, but modified as indicated 55 Once every 30 s All ventilation holes must be blocked 100% as described in WHO TobLabNet SOP 01. This method SOP was developed to direct participating labs in the specifics of carrying out the analysis of volatile organic components in mainstream cigarette smoke. For tobacco products other than cigarettes, specific parameters may have to be adjusted from those given in the document 1. SCOPE This method is suitable for quantitative determination of the following two volatile organics in mainstream cigarette smoke: benzene and 1,3-butadiene by combined gas chromatography mass spectrometry. Benzene and 1,3-butadiene are potent carcinogens. Benzene and 1,3-butadiene are not originally present in tobacco leaves but are formed from the combustion of organic material during cigarette burning. Note: Training in the use of the smoking machine and other analytical equipment is important for successful operation. For those not experienced in operating smoking machines or analyses using the analytical methods for measuring tobacco product emissions and contents, training should be obtained. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 9 2. REFERENCES 2.1 ISO 3308: Routine analytical cigarette-smoking machine – Definitions and standard conditions. Geneva: International Organization for Standardization; 2012. 2.2 ISO 4387: Cigarettes—Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. Geneva: International Organization for Standardization; 2000. 2.3 ISO 3402: Tobacco and tobacco products—Atmosphere for conditioning and testing. Geneva: International Organization for Standardization; 1999. 2.4 ISO 8243: Cigarettes—Sampling. Geneva: International Organization for Standardization; 2006. 2.5 ISO 5725-2: Accuracy (trueness and precision) or measurement methods and results—Part 2: Basic method for the determination of repeatability and reproducibility of a standard measurement method. 2.6 Tobacco Laboratory Network, Standard Operating Procedure for Intense Smoking (WHO TobLabNet SOP 01). ). Geneva: World Health Organization; 2012 (http:// apps.who.int/iris/bitstream/handle/10665/75261/9789241503891_eng. pdf;sequence=1, accessed 3 September 2018). 2.7 Tobacco Laboratory Network. Standard operating procedures for validation of alytical methods of tobacco product contents and emissions (WHO TobLabNet SOP 02). Geneva: World Health Organization., 2012 (http://apps. who.int/iris/bitstream/handle/10665/254998/9789241512060-eng. pdf?sequence=1, accessed 3 September, 2018). 2.8 Tobacco Laboratory Network. Standard Operating Procedure for the Determination of aldehydes in mainstream cigarette smoke under ISO and intense smoking conditions (WHO TobLabNet SOP 08). Geneva: World Health Organization; (jn press). 2.9 United Nations Office on Drugs and Crime. Guidelines on representative drug sampling. Vienna: Laboratory and Scientific Section; 2009 (http://www.unodc. org/documents/scientific/Drug_Sampling.pdf). 2.10 ISO 5725-1. Accuracy (trueness and precision) of measurement methods and results—Part 1: General principles and definitions. Geneva: International Organization for Standardization; 1994. 2.11 Uchiyama, S.; Tomizawa, T.; Inaba, Y.; Kunugita, N. Simultaneous determination of volatile organic comp unds and carbonyls i mainstream cigarette smoke using a sorbent cartridge followed by two-step elution. J Chromatogr A, 2013. 1314:31-7. doi: 10.1016/j.chroma.2013.09.019. 2.12 Uchiyama, S.; Haya hida, H.; Izu, R.; Inaba, Y.; Nakagome, H.; Kunugita, N. Determination of nicotine, tar, volatile organic compounds and carbonyls in mainstream cigarette smoke using a glass filter and a sorbent cartridge followed by the two-phase / one-pot elution method with carbon disulfide and methanol. Journal of Chromatography A 2015. 1426:48-55. doi.org/10.1016/j. chroma.2015.11.058. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 10 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3. TERMS AND DEFINITIONS CX-572: Carbon molecular sieves Carboxen 572 Intense Regime: Parameters for smoking tobacco products that include a 55-ml puff volume, a 30 s puff interval, 2 s puff duration and 100% blocking of filter ventilation hole ISO regime: Parameters for smoking tobacco pr ducts t at include a 35-ml puff volume, a 60 s puff interval, 2 s puff duration and no blocking of filter ventilation hole Laboratory sample: Sample intended for testing in a laboratory, consisting of a single type of product delivered to the laboratory at one time or within a specified period. Smoke trap: device for collecting such pa t of the smoke fr m a s mple of cig rettes as is necessary for the determination of specified smoke components. Test portion: Random portion from the test sample to be used for a single determination. The number of products taken shall be representative of the test sample. Test sample: Product to be tested, taken at random from the laborat ry sample. Th number of products taken shall be representative of the laboratory sample. Tobacco products: Products entirely or partly made of the leaf tobacco as raw material which are manufactured to be used for smoking, sucking, chewing or snuffing (Article 1(f) of the WHO FCTC) TPM: total particulate matter 4. METHOD SUMMARY 4.1 Mainstream cigarette smoke is performed according to the WHO Intense regime or the ISO regime. One cigarette is smoked per smoke trap containing 300 mg CX-572 particles and a glass fibre filter pad. 4.2 Mainstream smoke total particulate matter from the cigarette test sample is trapped onto a smoke trap containing 300 mg CX-572 particles and a glass- fibre filter pad (commonly referred to as a glass fibre filter pad). 4.3 The volatile organic components are extracted by adding a solution containing a mixture of carbon disulphide and methanol onto the Carboxen particles and glass fibre filter pad. 4.4 The analytical determination of VOCs (1,3-butadiene and benzene) is performed by gas chromatography–mass spectrometry (GC-MS) with electron ionization mode. 4.5 The reconstructed ion chromatogram peak area ratio of native analyte to labelled internal standard is compared on a calibration curve created by analysis of standards with known concentrations of the benzene and 1,3-butadiene to determine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 1 4.6 The benzene and 1,3-butadiene content of each test portion. 4.7 The method described in this SOP simultaneously tests and measures the level of aldehydes (SOP 08) and volatile organics (SOP 09) produced in mainstream cigarette smoke. 5. SAFETY AND ENVIRONMENTAL PRECAUTIONS 5.1 Follow routine safety and environmental precautions, as in any chemical laboratory activity. 5.2 The testing and evaluation of certain products with this test method may require the use of materials or equipment that could be hazardous or harmful to the environment; this document does not purport to address all the safety aspects associated with its use. All persons using this method have the responsibility to consult the appropriate authorities and to establish health and safety practices as well as environmental precautions in conjunction with any existing applicable regulatory requirements prior to its use. 5.3 Special care should be taken to avoid inhalation or dermal exposure to harmful chemicals. Use a chemical fume hood, and wear an appropriate laboratory coat, gloves and safety goggles when preparing or handling undiluted materials, standard solutions, extraction solutions or collected samples. 6. APPARATUS AND EQUIPMENT 6.1 Equipment needed to condition cigarettes as specified in ISO 3402 [2.3]. 6.2 Equipment needed to mark butt length as specified in ISO 4387 [2.2]. 6.3 Equipment needed to cover filter ventilation holes for the intense regimen as specified in WHO TobLabNet SOP 01 [2.6]. 6.4 Equipment needed to perform smoking of cigarette products as specified in ISO 3308 [2.1]. 6.5 Analytical balance capable of measurements to at least four decimal places. 6.6 Pipettes and tips capable of accurately dispensing volumes of 5–5000 μl. 6.7 Teflon-lined septa or equivalent. 6.8 Volumetric flasks 5 mL, 10 mL, 50 mL or equivalent. 6.9 Vials with septum seal, capacity of at least 20 mL (linear) or 50 mL (rotary) or equivalent. 6.10 Syringe, 1 mL and 5 mL or equivalent for transfer of organic solvent. 6.11 GC autosampler vials, 2 mL or equivalent. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 12 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 6.12 GC coupled with mass spectrometer det ctor. 6.13 GC column capable of distinct separation of benzene, 1,3-butadiene and isotopically labelled benzene peaks from other cigarette emission components, e.g. InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences or equivalent. 6.14 Carboxen 572 particles, 20/45 mesh size. 6.15 CX-572 cartridge: either manually prepared SPE cartridge filled with 300 mg of Carboxen 572 particles or preloaded CX-572 cartridge acquired by Sigma Aldrich (Cat. No. 54294-U). 6.16 Glass fibre filter pad as described in ISO 4387 [2.2] 6.17 Smoke trap set up consists of smoking machine holders attached with CX-572 (with or without cartridge) to be placed in front of glass fibre filter pad. (See Figs. 1 to 5). Note: Place the CX-572 cartridge in the holder facing the open side towa ds the cigarette. When positioned with the open end in the opposite direction, the content of the cartridge can be sucked into the smoking machine when puffs are taken. If necessary, special stopper can be inserted into the cartridge as shown in Fig. 6. Fig. 1a: Single port Borgwaldt Smoking Machine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 13 Fig. 1b: Linear Borgwaldt smoking machine Fig. 2a and Fig. 2b illustrate the cigarette holder suitable for use in commercial rotary smoking machine (i.e. Cerulean and/or Borgwaldt smoking machine) Fig. 2a: with the CX-572 particles weigh directly onto he holder Fig. 2b: with the CX-572 loaded cartridge inserted onto the holder Fig. 3: For Linear Cerulean smoking machine (also applicable to Linear Borgwaldt smoking machine) Note: CX-572 can be pre-packed into this holder or alternatively, a commercially available CX-572 cartridge can be used. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 14 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Fig. 4: For Linear Cerulean smoking m chine (also applicable to Linear B rgwaldt or Rotary Cerul an or single channel smoking machine) Fig. 5: For Linear Cerulean smoking m chine (also applicable to Linear Borgwaldt smoking machine) Fig. 6: Stoppers to be inserted into the CX-572 cartridges to prevent the contend to be sucked into the smoking machine Note: Be sure to put the cartridge into a closed vessel (vial) directly after inserting the stopper to prevent contamination of the CX-572. 7. REAGENTS AND SUPPLIES All reagents shall be of at least analytical reagent grade unless otherwise noted. When possible reagents are identified by their Chemical Abstract Service (CAS) registry numbers. 7.1 Benzene, analytical-grade. CAS number: 71-43-2. 7.2 Deuterium-labelled benzene (benzene-d6) purity>99%. CAS number: 1076- 43-3. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15 7.3 1,3-butadiene standard solution (2 mg/ml) [CAS number:106-99-0]. (AccuStandard, S-406A-10X). 7.4 Carbon disulfide, analytical-grade. CAS number: 75-15-0. 7.5 Methanol, anhydrous, analytical-grade. CAS number: 67-56-1. 7.6 Carboxen 572 particles, 20/45 mesh size (Sigma-Aldrich/Supelco Cat. No. 11072-U). 8. PREPARATION OF GLASSWARE Clean and dry glassware in a manner to avoid contamination from residues. 9. PREPARATION OF SOLUTIONS 9.1 Isotopically labelled internal standard solution (benzene-d6 5 mg/mL) 9.1.1 Weigh accurately 500 mg of benzene-d6 into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 9.1.2 Label and store at -20 oC ± 5 oC. 9.2 Extraction solution: The extraction solutions can be prepared with the following two options: 9.1.1 Option A: Carbon disulfide and methanol. 9.1.2 Option B: Carbon disulfide and methanol (1:4) mixed solution containing internal standard solution. Add 20 mL of carbon disulfide and 500 µL or 250 µL of internal standard solution (benzene-d6 5 mg/mL) to the 100 mL volumetric flask and dilute with methanol. The internal standard concentration of benzene-d6 is 25 µg/mL for linear or 12.5 µg/mL for rotary. 9.1.3 Carbon disulfide and methanol (1:4) mixed solution. Add 20 mL of carbon disulfide to the 100 mL volumetric flask and dilute with m thanol. Note: The amount of extraction solution prepared can be adjusted based on the need of the analysis. The following are for illustrative purposes only. 10. PREPARATION OF STANDARDS Note: can be adjusted accordingly with the condition that the standard range and internal standards concentration remains the same 10.1 VOCs (benzene 80 μg/mL and 1,3-butadiene 200 μg/mL) stock solutions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 16 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 10.1.1 Benzene 2.0 mg/mL standard solutio . Weigh accurately 200 mg of benzene [7.1] into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 10.1.2 Pipette 0.8 mL of the benzene standard solution [10.1] a d 2.0 mL of the 1,3-butadiene standard solution [7.3] into a 20 mL volumetric flask. 10.1.3 After addition of 4 mL of CS2 [7.4], the solution is diluted to 20 mL with methanol [7.5]. 10.1.4 Label and store at 4 °C ± 3 °C in amber vials. 10.2 VOCs working standard solutions 10.2.1 Depending on type of smoking machi e used, pipette variable volumes of the stock solution [10.1] and solvent mixture [9.2.3] into gas chromatography (GC) autosampler vials according to Table 1a (linear) or 1b (rotary). 10.2.2 Add isotopically labelled internal standard [9.1] according to Table 1a (linear) or 1b (rotary) and mix well. 10.2.3 Label and store at 4 °C ± 3 °C. Table 1a (option A). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 100 0 0 2 0.50 5 100 8 20 3 1.00 5 100 16 40 4 1.50 5 100 24 60 5 2.00 5 100 32 80 6 4.00 5 100 64 160 Table 1b (option A). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 50 0 0 2 0.25 5 50 4 10 3 0.50 5 50 8 20 4 0.75 5 50 12 30 5 1.00 5 50 16 40 6 2.00 5 50 32 80 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 17 Table 1c (option B). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 20 5 0 0 2 0.50 20 5 8 20 3 1.00 20 5 16 40 4 1.50 20 5 24 60 5 2.00 20 5 32 80 6 4.00 20 5 64 160 Table 1d (option B). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 10 5 0 0 2 0.25 10 5 4 10 3 0.50 10 5 8 20 4 0.75 10 5 12 30 5 1.00 10 5 16 40 6 2.50 10 5 40 100 The range of the working standard solutions may be adjusted depending on the equipment used and samples to be tested, keeping in mind the possible influence on the sensitivity of the applied method. All solvents and solutions must be adjusted to room temperature before use. 11. SAMPLING 11.1 Sample cigarettes according to ISO 8243 [2.4]. Alternative approaches may be used to obtain a representative laboratory sample in accordance with individual laboratory practice or when required by specific regulation or the availability of samples. 11.2 Constitution of test sample 11.2.1 Divide the laboratory sample into separate units (e.g. packet, container), if applicable. 11.2.2 Take an equal amount of product for each test sample from at least √n [2.9] of the individual units (e.g. packet, container). Note: Arbitrary sampling method is applied. √n is one of the method often used in practice and work well in many situations [2.9]. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 18 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 12. CIGARETTE PREPARATION 12.1 Condition all cigarettes to be smoked in accordance with ISO 3402 [2.3]. 12.2 Mark cigarettes at a butt length in accordance with ISO 4387 [2.2] and WHO TobLabNet SOP 01 [2.6]. 12.3 Prepare test samples to be smoked under Intense smoking conditions as specified in WHO TobLabNet SOP 01 [2.6]. 13. PREPARATION OF THE SMOKING MACHINE 13.1 Ambient conditions The ambient conditions for smoking are specified in ISO 3308 [2.1]. 13.2 Smoking machine specifications Follow ISO 3308 [2.1] machin specifications, except for int nse smoking, as described in WHO TobLabNet SOP 01 [2.6]. Prepare the smoke trap as described above [6.17] so that they are consistent with Figs. 1 to 5. 14. SAMPLE GENERATION 14.1 Smoke the cigarette test samples, as specified in ISO 4387 [2.2] or in WHO TobLabNet SOP 01 [2.6] and collect the volatile organic compounds of the mainstream smoke nto the smoke tr p [6.17] c ntaining th CX-572 cartridge [6.15] and glass fibre filter pad [6.16]. 14.2 Include at least one reference test sample to be used for quality control, if applicable. 14.3 The number of cigarettes to be smoked per measurement for linear and rotary smoking machines at ISO and intense smoking regimens are shown in Table 2. Table 2. Number of cigarettes to be smoked for one measurement in linear and rotary smoking machines. Refer to Appendix 4 for the appropriate smoking plan. ISO smoking regimen Intense smoking regimen Linear Rotary Linear Rotary No. of cigarettes per smoke trap 1 1 1 1 No. of smoke traps per result 3 3 3 3 Note: Smoke 1 cigarette on the specified smoking machine such that breakthrough does not occur and the concentrations of benzene and 1,3- butadiene fall within the calibration range prepared for the analysis. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19 14.4 Record the number of cigarettes and total puffs for each smoke trap. 14.5 After smoking the required number of test samples, perform one clearing puff, and remove the smoke trap from the smoking machine. 14.6 One result is an average of three measurements. 14.7 Blank measurement is made on 10 puffs at least once per day before smoking cigarette samples. Fig. 7: Overview of the analytical procedure for simultaneous determination of aldehydes (SOP 08) and volatile organics (SOP 09) in mainstream cigarette smoke 15. SAMPLE PREP RATION Extraction (there are two options: individually add CS2 followed by MeOH (option A) or using a mixture of extraction solution (option B). World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 20 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15.1 Option A (15.1.1 to 15.1.7) 15.1.1 Add 2 mL (for linear) or 4 mL (for rotary) of carbon disulfide [7.4] into the vial or flask [6.9]. Slowly add 8 mL (for linear) or 16 mL (for rotary) of methanol. DO NOT MIX the two solutions. CX-572 is added quickly into the two-phase solution. 15.1.2 After bubbling stop, swirl gently and place the glass fibre filter pad into the vial or flask. 15.1.3 Close the vial or flask. 15.1.4 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles per min. 15.1.5 Let the sample stand for at least one minute (or until the particles settle). 15.1.6 Transfer 5 mL of the supernatant solution into a vial and add 100 µl (for linear) or 50 µl (f r r tary) of int rnal standard solution [9.1]. 15.1.7 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 15.2 Option B [15.2.1 to 15.2.5] 15.2.1 Immediately transfer the Carb xen 572 arti les and the glass fibre filter pad into the vial or flask [6.9]. 15.2.2 Add slowly 10 mL (for linear) 20 mL (for rotary) of solvent mixture [9.2.2] into the vial or flask. Close the vial or flask i mediately. 15.2.3 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles or rounds per min. 15.2.4 Let the sample stand for at least one minute (or until the particles settle). 15.2.5 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 16. SAMPLE ANALYSIS This method utilizes gas chromatograph coupled with GC-MS to quantify benzene and 1,3-butadiene in mainstream cigarette smoke. The analytes are resolved from other potential interference on the column used. Comparison of the area ratio (native analyte area/isotope-labelled analyte area) of the unknowns with the concentration of known standard concentrations yields individual analyte concentrations. 16.1 Gas chromatography and mass spectrometer operating conditions 16.1.1 Gas chromatography conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 2 Table 3. This section illustrates an example of GC equipment and its operating conditions. GC Column InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences Injector temperature: 240 oC (iontrap: 200 °C) Mode: Constant flow Flow rate: 1.0 mL/min (iontrap 1.0 mL/min) Injection: 1 µL or 2 µL with split ratio 1:10 (Ion trap 1:5 after 1.5 mins 1:120) Column temperature: 40 °C for 6 mins 6 °C/min to 250 °C Total run time 45 mins Interface/Transfer line temperature: 180 °C (iontrap 200 °C) • For the conditions described here, the expected sequence of elution will be 1,3-butadiene, carbon disulfide, benzene-d6 and benzene. • It is expected that differences, such as in flow rate, mobile phase concentration, age of the column, will alter retention times. • The elution order and retention times must be verified before analysis is begun. • Using the above conditions, the expected total analysis time will be about 60 minutes. Note: Adjustment of the op rating parameters may be required, depending on the instrument and column conditions as well as the resolution of the chromatographic peaks. 16.1.2 Mass spectrometer conditions and peak identification Table 4. The acquisition of the m/z signals is performed in full scan mode: Ion source: 200 °C ( ion trap 180°C) Dwell time 50 msec Ionization mode: Electron Ionization (ionizing voltage at 70 eV) Detection: Full-scan m/z 30-300 Ion peak for identification Benzene : m/z 78 Benzene – d6: m/z 84 1,3-Butadiene: m/z 54 16.2 VOCs Determination 16.2.1 Condition the system just prior to use by injecting two 1 µl or 2 µl aliquots of a sample solution as a primer. 16.2.2 Inject a check standard (blank with internal standard) under the same conditions as the samples to verify the performance of the GC-MS system. 16.2.3 Inject a blank (extraction solution) to check any contamination in the system or extraction solution or reagents. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 22 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 16.2.4 Inject an aliquot of each working standard solution into the GC-MS. 16.2.5 Assess the retention times and relative response ratio (based on area counts) for the labelled standards. If the retention times are similar (± 0.2 min) to the retention times and relative response ratio are within ± 20% of the typical responses from the previous runs, the system is ready to perform the analysis. 16.2.6 Inject the calibration standards, quality controls (QCs), and samples and determine peak areas and relative response ratio using the instrument software. 16.2.7 Record the peak areas of benzene, 1,3-butadiene and benzene-d6. 16.2.8 Calculate the ratio of the Benzene peak to the internal standard peak (RF = ABenzene/ABenzene-d6) for each of the Benzene and 1,3-butadiene standard solutions including the standard blanks. 16.2.9 Plot the graph of the concentration of added benzene (X axis) in accordance with the area ratios (Y axis). 16.2.10 The intercept should not be statistically significantly different from zero. 16.2.11 Linearity of the standard curve should extend over the entire standard range. 16.2.12 Calculate the linear regression (Y = a + bx) from these data, and use both the slope (b) and the intercept (a) of the inear regression. If the linear regression R2 is less than 0,99, the calibration should be repeated. If an individual calibration point differs by more than 10% from the expected value (estimated by linear regression), this point should be omitted. 16.2.13 Inject the QCs and samples and determine peak areas using the instrument software. 16.2.14 The relative response factors (peak area ratio) obtained for all test portions must fall within the working range of the calibration curve. Note: See Appendix 1 for representative chromatograms. 17. DATA ANALYSIS AND CALCULATIONS The slope and intercept are determined from the relative responses of the analyte and the labelled standard versus the relative concentrations of the analyte and the labelled standard. 17.1 Calculate the relative response ratio from the peak areas for each of the volatile organics for each of the calibration standards [10.2.3]: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 23 where: RF = relative response ratio Aa= area of the target analyte AIS= area of the corresponding internal standard. Plot a graph for each of the volatile organics, of the relative response factor, Aa /AIS , (Y axis) versus concentration (X axis). Calculate a linear regression equation (RF = kX + m) from these data, and use both the slope (k) and the intercept (m) of the linear regression. 17.2 The linearity of the standard curve should cover the entire standard range. 17.3 The content MVOCs of a given volatile organics of the target analyte (µg/ cigarette) is determined from he calculated rel tive response ratio for the test portion, the slope and intercept obtained from the appropriate calibration curve, and the equation: where: MVOCs = calculated content, in µg/cigarette V = volume of extraction solution (10 ml or 20 mL) N = 1 (number of cigarette smoked onto each cartridge). RF = Relative response ratio m = intercept of the Y-axis of the calibration curve k = slope of the calibration curve Alternative calculation procedures may be used if applicable. 18. SPECIAL PRECAUTIONS After installing a new colum , condition it as specified by the manufacturer by injecting a tobacco sample extract under the specified instrument conditions. Injections should be repeated until the peak areas (or heights) of each of the volatile organics and the internal standards are reproducible. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 24 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19. DATA REPORTING 19.1 Report individual measurements for each of the samples evaluated. 19.2 Report results as specified by method specifications. 19.3 For more information, see WHO TobLabNet SOP 02 [2.7]. 20. QUALITY CONTROL 20.1 Control parameters Note: If the control me surements ar outside th tolerance limits of the expected values, appropriate investigation and action must be taken. Note: Additional laboratory quality assurance procedures should be carried out in compliance with the policies of the individual laboratory. 20.2 Laboratory reagent blank To detect potential contamination during sample preparation and analysis, include a laboratory reagent blank, as described in [16.2.3]. The blank consists of all reagents and materials used in analysing test samples, including the extraction of CX-572 and glass fibre filter pad, and is analysed like a test sample. The assessment of the blank should be less than the limit of detection. 20.3 Quality control sampl To verify the consistency f the entir analy ical process, analyse a reference cigarette in accordance with the practices of the individual laboratory. 20.4 Additional QC Additional QC samples may be added as consistent with laboratory policy. 21. METHOD PERFORMANCE SPECIFICATIONS 21.2 Limit of Report (LOR) The LOR is set to the lowest concentration of the calibration standards used, recalculated to ng/cigarette (0.05 µmol/mL as the lowest calibration solution). 21.2 Laboratory fortified matrix recovery Recovery of analyte spiked onto the matrix is used as a surrogate measure of accuracy. Recovery is determined by spiking known amounts of standards (after smoking) and extracting by the same method as used for samples. Unspiked samples are also analysed. The recovery is calculated from the following formula and as shown in Table 5 below: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 25 Recovery = 100 × (analytical result – unspiked result/spiked amount) Table 5. Mean and recovery spiked onto the matrix (to be added after the completion of the validation) Benzene 1,3-butadiene Spiked amount (µg) Mean (mg) Recovery (%) Spiked amount (µg) Mean (mg) Recovery (%) 16.9 18.4 108.9 10 9.4 94.0 33.8 37.0 109.5 20 18.6 93.0 67.6 75.2 111.2 40 41.9 104.8 21.4 Analytical specificity GC-MS provides excellent analytical specificity. The retention time, the confirmation ion ratio, an established range of ratios of the response of the quantification ion to that of the confirmation ion and quality control samples are used to verify the specificity of the results for an unknown sample. 21.5 Linearity The volatile organics calibration curves established are linear over the standard concentration range of 0.5–200 ng/mL. 21.6 Possible interference There are no known components that can cause an interference by having both a similar retention time and confirmation ion pair ratio as volatile organics or the internal standards. 22. REPEATABILITY AND REPRODUCIBILITY An international collaborative study conducted from 2015–2017, involving 10 laboratories and five samples (three reference cigarettes and two commercial brands), performed according to WHO TobLabNet SOP 02 (2.7) gave the following precision limits for this method. The difference between two single results found on matched cigarette samples by the same operator using the same apparatus within the shortest feasible time interval will exceed the repeatability, r, on average not more than once in 20 cases in the normal and correct operation of the method. Single results on matched cigarette samples reported by two laboratories will differ by more than the reproducibility, R, on average not more than once in 20 cases in the normal and correct operation of the method. The test results were analysed statistically in accordance with ISO 5725-1 [2.10] and ISO 5725-2 [2.5] to give the precision data shown in Tables 6–7. For the purpose of calculating r and R, one test result under ISO smoking conditions was defined as the average of seven individual replicates of the mean yield of three smoke traps (one cigarette smoked per smoke trap) from linear smoking machines and World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 26 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions three smoke traps for rot ry smoking machines. Under i tense smoking conditions, one test result was defined as the average of seven individual replicates of the mean yield of three smoke traps fr m li ear smoking machines and three smoke traps for rotary smoking machines. For mor information, see reference [2.6]. Table 6a and 6b. Precision limits for determination of 1,3-butadiene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette 1,3-butadiene: ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 11.06 1.96 4.27 3R4F 9 39.23 7.20 16.34 CM6 6 60. 6 1.74 2.18 Commercial Brand I 8 72.71 8.03 42.79 Commercial Brand II 8 61.58 9.97 16.80 Reference cigarette 1,3-butadiene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 7 82.26 8.11 8.63 3R4F 8 92.22 11.51 13.18 CM6 7 106.20 12.59 12.67 Commercial Brand I 8 153.96 17.20 70.04 Commercial Brand II 6 141.52 11.00 14.55 Table 7a and 7b. Precision limits for determination of Benzene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette benzen : ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 9 13.47 2.54 6.46 3R4F 9 44.50 6.94 10.15 CM6 8 72.86 5.94 11.40 Commercial Brand I 9 58.78 6.54 15.18 Commercial Brand II 9 49.94 8.83 15.37 Reference cigarette benzene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 85.59 8.17 16.68 3R4F 9 95.95 8.49 40.92 CM6 8 108.35 6.93 23.52 Commercial Brand I 8 122.00 7.21 48.76 Commercial Brand II 8 111.77 6.60 36.32 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 27 Appendix 1. Typical chromatograms obtained in the determination of volatile organics in mainstream cigarette smoke Fig. A1. Representative chromatogram of standard 21 Total ion chromatogram of a mixed standard solution. BD, 1,3-butadiene; BZ- d6, benzene-d6; BZ, benzene Fig. A2. Representative chromatogram of volatile organics in cigarette mainstream smoke2 Total ion chromatogram of a sample solution. BD, 1,3-butadiene; BZ-d6, benzene-d6; BZ, benzene 1 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. 2 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 28 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Appendix 2: Smoking Plans The described smoking plans are based on five different samples (cigarettes brand/ types) and seven replicates per sample. If a different number of sa ples or replicates is needed the plans should be adjusted accordingly. Smoking plan for 20-port linear smoking machine (one cigarette per cartridge) D ay Port number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 A B C D E A B C D E A B C D E 2 D E A B C D E A B C D E A B C 3 B C C D E A B C D E A B D E A 4 E A B C D E A B C D E A B C D 5 C D E A B C D E A B C D E A B 6 D C B A E D C B A E D C B A E 7 C B A E D C B A E D C B A E D Smoking plan for rotary smoking machine (one cigarette per cartridge) Day Run Sample Day Run Sample Day Run Sample Day Run Sample World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 29 1 1 A 3 31 B 5 61 C 7 91 C 2 A 32 B 62 C 92 C 3 A 33 B 63 C 93 C 4 B 34 C 64 D 94 B 5 B 35 C 65 D 95 B 6 B 36 C 66 D 96 B 7 C 37 D 67 E 97 A 8 C 38 D 68 E 98 A 9 C 39 D 69 E 99 A 10 D 40 E 70 A 100 E 11 D 41 E 71 A 101 E 12 D 42 E 72 A 102 E 13 E 43 A 73 B 103 D 14 E 44 A 74 B 104 D 15 E 45 A 75 B 105 D 2 16 D 4 46 E 6 76 D 17 D 47 E 77 D 18 D 48 E 78 D 19 E 49 A 79 C 20 E 50 A 80 C 21 E 51 A 81 C 22 A 52 B 82 B 23 A 53 B 83 B 24 A 54 B 84 B 25 B 55 C 85 A 26 B 56 C 86 A 27 B 57 C 87 A 28 C 58 D 88 E 29 C 59 D 89 E 30 C 60 D 90 E This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions.

WHO TobLabNet Official Method SOP 09 Standard Operating prOcedure fOr determinatiOn Of VOlatile OrganicS in mainStream cigarette SmOke under iSO and intenSe SmOking cOnditiOnS Tobacco Free Initiative Tobacco Laboratory Network (TobLabNet) World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3 WHO TobLabNet Official Method SOP 09 Standard operating pr cedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 4 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Standard operating procedure for etermination of volatile organics in ainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09 ISBN 978-92-4-151477-4 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine w ther permission is needed for that reuse a d to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Printed in Switzerland World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 5 No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: Benzene (CAS# 71-43-2) 1,3-butadiene (CAS# 106-99-0) Matrix: Tobacc cigarette mainstream smoke particulate matter Last update: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 6 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions No machine smoking regimen an represent all human smoking behaviour: machine smoking testing is useful for characterizing cigarette emissions for des gn and regulatory purp ses, but communication of machine measurements to smokers can result in misunderstanding about differ nces b tween brands in exposure and risk. Data on smoke emissions from machine measurements may be used as inputs for product hazard assessment, but they are not intended to be nor are they valid as measur of human exposure or risks. Representing differences in machine measurements as differences in exposure or risk is a misuse of testing w th WHO TobLabNet standards. No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 7 FOREWORD This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for measuring volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions. INTRODUCTION In order to establish comparable measurements for testing tobacco products globally, consensus methods are required for measuring specific contents and emissions of cigarettes. The Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (WHO FCTC) at its third session in Durban, South Africa, in November 2008, recalling its decisions FCTC/COP1(15) and FCTC/COP2(14) on the elaboration of guidelines for implementation of Articles 9 (Regulation of the contents of tobacco products) and 10 (Regulation of tobacco product disclosures) of the WHO FCTC, noting the information contained in the report of the working group to the third session of the Conference of the Parties on the progress of its work … requested the Convention Secretariat to invite WHO’s Tobacco Free Initiative to “validate, within five years, the analytical chemical methods for testing and measuring cigarette contents and emissions”.1 Using the criteria for prioritization set at its third meeting in Ottawa, Canada, in October 2006, the working group on Articles 9 and 10 identified the following contents for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • nicotine • ammonia • humectants (propane-1,2-diol, glycerol (propane-1,2,3-triol) and triethylene glycol (2,2-ethylenedioxybis(ethanol)). Measurement of these contents will require validation of three methods: one for nicotine, one for ammonia and one for humectants. Using the criteria for prioritiz ti set at the meeting i Ottawa m ntioned above, the working group ident fied the following emissions in mainstream smoke for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) • N-nitrosonornicotine (NNN) 1 Decision, third session of the Conference of the Parties to the WHO FCTC; 2008 (http://apps.who. int/gb/fctc/PDF/cop3/FCTC_COP3_REC1- n.pdf). No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 8 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions • acetaldehyde • acrylaldehyde (acrolein) • benzene • benzo[a]pyrene • 1,3-butadiene • carbon monoxide • formaldehyde Measurement of these emissions with the two smoking r gimens described below will require validation of four methods: one for tobacco-specific nitrosamines (NNK and NNN), one for benzo[a]pyrene, one for aldehydes (acetaldehyde, acrolein and formaldehyde), one for volatile organic compounds (benzene, 1,3-butadiene) and one for carbon monoxide. The table below sets out the two smoking regimens for validation of the test methods referred to above. Smoking regimen Puff volume (mL) Puff frequency Filter ventilation holes ISO regimen: ISO 3308; Routine analytical cigarette smoking machine—definitions and standard conditions 35 Once every 60 s No modifications Intense regimen: Same as ISO 3308, but modified as indicated 55 Once every 30 s All ventilation holes must be blocked 100% as described in WHO TobLabNet SOP 01. This method SOP was developed to direct participating labs in the specifics of carrying out the analysis of volatile organic components in mainstream cigarette smoke. For tobacco products other than cigarettes, specific parameters may have to be adjusted from those given in the document 1. SCOPE This method is suitable for quantitative determination of the following two volatile organics in mainstream cigarette smoke: benzene and 1,3-butadiene by combined gas chromatography mass spectrometry. Benzene and 1,3-butadiene are potent carcinogens. Benzene and 1,3-butadiene are not originally present in tobacco leaves but are formed from the combustion of organic material during cigarette burning. Note: Training in the use of the smoking machine and other analytical equipment is important for successful operation. For those not experienced in operating smoking machines or analyses using the analytical methods for measuring tobacco product emissions and contents, training should be obtained. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 9 2. REFERENCES 2.1 ISO 3308: Routine analytical cigarette-smoking machine – Definitions and standard conditions. Geneva: International Organization for Standardization; 2012. 2.2 ISO 4387: Cigarettes—Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. Geneva: International Organization for Standardization; 2000. 2.3 ISO 3402: Tobacco and tobacco products—Atmosphere for conditioning and testing. Geneva: International Organization for Standardization; 1999. 2.4 ISO 8243: Cigarettes—Sampling. Geneva: International Organization for Standardization; 2006. 2.5 ISO 5725-2: Accuracy (trueness and precision) or measurement methods and results—Part 2: Basic method for the determination of repeatability and reproducibility of a standard measurement method. 2.6 Tobacco Laboratory Network, Standard Operating Procedure for Intense Smoking (WHO TobLabNet SOP 01). ). Geneva: World Health Organization; 2012 (http:// apps.who.int/iris/bitstream/handle/10665/75261/9789241503891_eng. pdf;sequence=1, accessed 3 September 2018). 2.7 Tobacco Laboratory Network. Standard operating procedures for validation of alytical methods of tobacco product contents and emissions (WHO TobLabNet SOP 02). Geneva: World Health Organization., 2012 (http://apps. who.int/iris/bitstream/handle/10665/254998/9789241512060-eng. pdf?sequence=1, accessed 3 September, 2018). 2.8 Tobacco Laboratory Network. Standard Operating Procedure for the Determination of aldehydes in mainstream cigarette smoke under ISO and intense smoking conditions (WHO TobLabNet SOP 08). Geneva: World Health Organization; (jn press). 2.9 United Nations Office on Drugs and Crime. Guidelines on representative drug sampling. Vienna: Laboratory and Scientific Section; 2009 (http://www.unodc. org/documents/scientific/Drug_Sampling.pdf). 2.10 ISO 5725-1. Accuracy (trueness and precision) of measurement methods and results—Part 1: General principles and definitions. Geneva: International Organization for Standardization; 1994. 2.11 Uchiyama, S.; Tomizawa, T.; Inaba, Y.; Kunugita, N. Simultaneous determination of volatile organic comp unds and carbonyls i mainstream cigarette smoke using a sorbent cartridge followed by two-step elution. J Chromatogr A, 2013. 1314:31-7. doi: 10.1016/j.chroma.2013.09.019. 2.12 Uchiyama, S.; Haya hida, H.; Izu, R.; Inaba, Y.; Nakagome, H.; Kunugita, N. Determination of nicotine, tar, volatile organic compounds and carbonyls in mainstream cigarette smoke using a glass filter and a sorbent cartridge followed by the two-phase / one-pot elution method with carbon disulfide and methanol. Journal of Chromatography A 2015. 1426:48-55. doi.org/10.1016/j. chroma.2015.11.058. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 10 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3. TERMS AND DEFINITIONS CX-572: Carbon molecular sieves Carboxen 572 Intense Regime: Parameters for smoking tobacco products that include a 55-ml puff volume, a 30 s puff interval, 2 s puff duration and 100% blocking of filter ventilation hole ISO regime: Parameters for smoking tobacco pr ducts t at include a 35-ml puff volume, a 60 s puff interval, 2 s puff duration and no blocking of filter ventilation hole Laboratory sample: Sample intended for testing in a laboratory, consisting of a single type of product delivered to the laboratory at one time or within a specified period. Smoke trap: device for collecting such pa t of the smoke fr m a s mple of cig rettes as is necessary for the determination of specified smoke components. Test portion: Random portion from the test sample to be used for a single determination. The number of products taken shall be representative of the test sample. Test sample: Product to be tested, taken at random from the laborat ry sample. Th number of products taken shall be representative of the laboratory sample. Tobacco products: Products entirely or partly made of the leaf tobacco as raw material which are manufactured to be used for smoking, sucking, chewing or snuffing (Article 1(f) of the WHO FCTC) TPM: total particulate matter 4. METHOD SUMMARY 4.1 Mainstream cigarette smoke is performed according to the WHO Intense regime or the ISO regime. One cigarette is smoked per smoke trap containing 300 mg CX-572 particles and a glass fibre filter pad. 4.2 Mainstream smoke total particulate matter from the cigarette test sample is trapped onto a smoke trap containing 300 mg CX-572 particles and a glass- fibre filter pad (commonly referred to as a glass fibre filter pad). 4.3 The volatile organic components are extracted by adding a solution containing a mixture of carbon disulphide and methanol onto the Carboxen particles and glass fibre filter pad. 4.4 The analytical determination of VOCs (1,3-butadiene and benzene) is performed by gas chromatography–mass spectrometry (GC-MS) with electron ionization mode. 4.5 The reconstructed ion chromatogram peak area ratio of native analyte to labelled internal standard is compared on a calibration curve created by analysis of standards with known concentrations of the benzene and 1,3-butadiene to determine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 1 4.6 The benzene and 1,3-butadiene content of each test portion. 4.7 The method described in this SOP simultaneously tests and measures the level of aldehydes (SOP 08) and volatile organics (SOP 09) produced in mainstream cigarette smoke. 5. SAFETY AND ENVIRONMENTAL PRECAUTIONS 5.1 Follow routine safety and environmental precautions, as in any chemical laboratory activity. 5.2 The testing and evaluation of certain products with this test method may require the use of materials or equipment that could be hazardous or harmful to the environment; this document does not purport to address all the safety aspects associated with its use. All persons using this method have the responsibility to consult the appropriate authorities and to establish health and safety practices as well as environmental precautions in conjunction with any existing applicable regulatory requirements prior to its use. 5.3 Special care should be taken to avoid inhalation or dermal exposure to harmful chemicals. Use a chemical fume hood, and wear an appropriate laboratory coat, gloves and safety goggles when preparing or handling undiluted materials, standard solutions, extraction solutions or collected samples. 6. APPARATUS AND EQUIPMENT 6.1 Equipment needed to condition cigarettes as specified in ISO 3402 [2.3]. 6.2 Equipment needed to mark butt length as specified in ISO 4387 [2.2]. 6.3 Equipment needed to cover filter ventilation holes for the intense regimen as specified in WHO TobLabNet SOP 01 [2.6]. 6.4 Equipment needed to perform smoking of cigarette products as specified in ISO 3308 [2.1]. 6.5 Analytical balance capable of measurements to at least four decimal places. 6.6 Pipettes and tips capable of accurately dispensing volumes of 5–5000 μl. 6.7 Teflon-lined septa or equivalent. 6.8 Volumetric flasks 5 mL, 10 mL, 50 mL or equivalent. 6.9 Vials with septum seal, capacity of at least 20 mL (linear) or 50 mL (rotary) or equivalent. 6.10 Syringe, 1 mL and 5 mL or equivalent for transfer of organic solvent. 6.11 GC autosampler vials, 2 mL or equivalent. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 12 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 6.12 GC coupled with mass spectrometer det ctor. 6.13 GC column capable of distinct separation of benzene, 1,3-butadiene and isotopically labelled benzene peaks from other cigarette emission components, e.g. InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences or equivalent. 6.14 Carboxen 572 particles, 20/45 mesh size. 6.15 CX-572 cartridge: either manually prepared SPE cartridge filled with 300 mg of Carboxen 572 particles or preloaded CX-572 cartridge acquired by Sigma Aldrich (Cat. No. 54294-U). 6.16 Glass fibre filter pad as described in ISO 4387 [2.2] 6.17 Smoke trap set up consists of smoking machine holders attached with CX-572 (with or without cartridge) to be placed in front of glass fibre filter pad. (See Figs. 1 to 5). Note: Place the CX-572 cartridge in the holder facing the open side towa ds the cigarette. When positioned with the open end in the opposite direction, the content of the cartridge can be sucked into the smoking machine when puffs are taken. If necessary, special stopper can be inserted into the cartridge as shown in Fig. 6. Fig. 1a: Single port Borgwaldt Smoking Machine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 13 Fig. 1b: Linear Borgwaldt smoking machine Fig. 2a and Fig. 2b illustrate the cigarette holder suitable for use in commercial rotary smoking machine (i.e. Cerulean and/or Borgwaldt smoking machine) Fig. 2a: with the CX-572 particles weigh directly onto he holder Fig. 2b: with the CX-572 loaded cartridge inserted onto the holder Fig. 3: For Linear Cerulean smoking machine (also applicable to Linear Borgwaldt smoking machine) Note: CX-572 can be pre-packed into this holder or alternatively, a commercially available CX-572 cartridge can be used. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 14 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Fig. 4: For Linear Cerulean smoking m chine (also applicable to Linear B rgwaldt or Rotary Cerul an or single channel smoking machine) Fig. 5: For Linear Cerulean smoking m chine (also applicable to Linear Borgwaldt smoking machine) Fig. 6: Stoppers to be inserted into the CX-572 cartridges to prevent the contend to be sucked into the smoking machine Note: Be sure to put the cartridge into a closed vessel (vial) directly after inserting the stopper to prevent contamination of the CX-572. 7. REAGENTS AND SUPPLIES All reagents shall be of at least analytical reagent grade unless otherwise noted. When possible reagents are identified by their Chemical Abstract Service (CAS) registry numbers. 7.1 Benzene, analytical-grade. CAS number: 71-43-2. 7.2 Deuterium-labelled benzene (benzene-d6) purity>99%. CAS number: 1076- 43-3. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15 7.3 1,3-butadiene standard solution (2 mg/ml) [CAS number:106-99-0]. (AccuStandard, S-406A-10X). 7.4 Carbon disulfide, analytical-grade. CAS number: 75-15-0. 7.5 Methanol, anhydrous, analytical-grade. CAS number: 67-56-1. 7.6 Carboxen 572 particles, 20/45 mesh size (Sigma-Aldrich/Supelco Cat. No. 11072-U). 8. PREPARATION OF GLASSWARE Clean and dry glassware in a manner to avoid contamination from residues. 9. PREPARATION OF SOLUTIONS 9.1 Isotopically labelled internal standard solution (benzene-d6 5 mg/mL) 9.1.1 Weigh accurately 500 mg of benzene-d6 into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 9.1.2 Label and store at -20 oC ± 5 oC. 9.2 Extraction solution: The extraction solutions can be prepared with the following two options: 9.1.1 Option A: Carbon disulfide and methanol. 9.1.2 Option B: Carbon disulfide and methanol (1:4) mixed solution containing internal standard solution. Add 20 mL of carbon disulfide and 500 µL or 250 µL of internal standard solution (benzene-d6 5 mg/mL) to the 100 mL volumetric flask and dilute with methanol. The internal standard concentration of benzene-d6 is 25 µg/mL for linear or 12.5 µg/mL for rotary. 9.1.3 Carbon disulfide and methanol (1:4) mixed solution. Add 20 mL of carbon disulfide to the 100 mL volumetric flask and dilute with m thanol. Note: The amount of extraction solution prepared can be adjusted based on the need of the analysis. The following are for illustrative purposes only. 10. PREPARATION OF STANDARDS Note: can be adjusted accordingly with the condition that the standard range and internal standards concentration remains the same 10.1 VOCs (benzene 80 μg/mL and 1,3-butadiene 200 μg/mL) stock solutions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 16 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 10.1.1 Benzene 2.0 mg/mL standard solutio . Weigh accurately 200 mg of benzene [7.1] into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 10.1.2 Pipette 0.8 mL of the benzene standard solution [10.1] a d 2.0 mL of the 1,3-butadiene standard solution [7.3] into a 20 mL volumetric flask. 10.1.3 After addition of 4 mL of CS2 [7.4], the solution is diluted to 20 mL with methanol [7.5]. 10.1.4 Label and store at 4 °C ± 3 °C in amber vials. 10.2 VOCs working standard solutions 10.2.1 Depending on type of smoking machi e used, pipette variable volumes of the stock solution [10.1] and solvent mixture [9.2.3] into gas chromatography (GC) autosampler vials according to Table 1a (linear) or 1b (rotary). 10.2.2 Add isotopically labelled internal standard [9.1] according to Table 1a (linear) or 1b (rotary) and mix well. 10.2.3 Label and store at 4 °C ± 3 °C. Table 1a (option A). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 100 0 0 2 0.50 5 100 8 20 3 1.00 5 100 16 40 4 1.50 5 100 24 60 5 2.00 5 100 32 80 6 4.00 5 100 64 160 Table 1b (option A). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 50 0 0 2 0.25 5 50 4 10 3 0.50 5 50 8 20 4 0.75 5 50 12 30 5 1.00 5 50 16 40 6 2.00 5 50 32 80 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 17 Table 1c (option B). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 20 5 0 0 2 0.50 20 5 8 20 3 1.00 20 5 16 40 4 1.50 20 5 24 60 5 2.00 20 5 32 80 6 4.00 20 5 64 160 Table 1d (option B). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 10 5 0 0 2 0.25 10 5 4 10 3 0.50 10 5 8 20 4 0.75 10 5 12 30 5 1.00 10 5 16 40 6 2.50 10 5 40 100 The range of the working standard solutions may be adjusted depending on the equipment used and samples to be tested, keeping in mind the possible influence on the sensitivity of the applied method. All solvents and solutions must be adjusted to room temperature before use. 11. SAMPLING 11.1 Sample cigarettes according to ISO 8243 [2.4]. Alternative approaches may be used to obtain a representative laboratory sample in accordance with individual laboratory practice or when required by specific regulation or the availability of samples. 11.2 Constitution of test sample 11.2.1 Divide the laboratory sample into separate units (e.g. packet, container), if applicable. 11.2.2 Take an equal amount of product for each test sample from at least √n [2.9] of the individual units (e.g. packet, container). Note: Arbitrary sampling method is applied. √n is one of the method often used in practice and work well in many situations [2.9]. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 18 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 12. CIGARETTE PREPARATION 12.1 Condition all cigarettes to be smoked in accordance with ISO 3402 [2.3]. 12.2 Mark cigarettes at a butt length in accordance with ISO 4387 [2.2] and WHO TobLabNet SOP 01 [2.6]. 12.3 Prepare test samples to be smoked under Intense smoking conditions as specified in WHO TobLabNet SOP 01 [2.6]. 13. PREPARATION OF THE SMOKING MACHINE 13.1 Ambient conditions The ambient conditions for smoking are specified in ISO 3308 [2.1]. 13.2 Smoking machine specifications Follow ISO 3308 [2.1] machin specifications, except for int nse smoking, as described in WHO TobLabNet SOP 01 [2.6]. Prepare the smoke trap as described above [6.17] so that they are consistent with Figs. 1 to 5. 14. SAMPLE GENERATION 14.1 Smoke the cigarette test samples, as specified in ISO 4387 [2.2] or in WHO TobLabNet SOP 01 [2.6] and collect the volatile organic compounds of the mainstream smoke nto the smoke tr p [6.17] c ntaining th CX-572 cartridge [6.15] and glass fibre filter pad [6.16]. 14.2 Include at least one reference test sample to be used for quality control, if applicable. 14.3 The number of cigarettes to be smoked per measurement for linear and rotary smoking machines at ISO and intense smoking regimens are shown in Table 2. Table 2. Number of cigarettes to be smoked for one measurement in linear and rotary smoking machines. Refer to Appendix 4 for the appropriate smoking plan. ISO smoking regimen Intense smoking regimen Linear Rotary Linear Rotary No. of cigarettes per smoke trap 1 1 1 1 No. of smoke traps per result 3 3 3 3 Note: Smoke 1 cigarette on the specified smoking machine such that breakthrough does not occur and the concentrations of benzene and 1,3- butadiene fall within the calibration range prepared for the analysis. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19 14.4 Record the number of cigarettes and total puffs for each smoke trap. 14.5 After smoking the required number of test samples, perform one clearing puff, and remove the smoke trap from the smoking machine. 14.6 One result is an average of three measurements. 14.7 Blank measurement is made on 10 puffs at least once per day before smoking cigarette samples. Fig. 7: Overview of the analytical procedure for simultaneous determination of aldehydes (SOP 08) and volatile organics (SOP 09) in mainstream cigarette smoke 15. SAMPLE PREP RATION Extraction (there are two options: individually add CS2 followed by MeOH (option A) or using a mixture of extraction solution (option B). World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 20 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15.1 Option A (15.1.1 to 15.1.7) 15.1.1 Add 2 mL (for linear) or 4 mL (for rotary) of carbon disulfide [7.4] into the vial or flask [6.9]. Slowly add 8 mL (for linear) or 16 mL (for rotary) of methanol. DO NOT MIX the two solutions. CX-572 is added quickly into the two-phase solution. 15.1.2 After bubbling stop, swirl gently and place the glass fibre filter pad into the vial or flask. 15.1.3 Close the vial or flask. 15.1.4 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles per min. 15.1.5 Let the sample stand for at least one minute (or until the particles settle). 15.1.6 Transfer 5 mL of the supernatant solution into a vial and add 100 µl (for linear) or 50 µl (f r r tary) of int rnal standard solution [9.1]. 15.1.7 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 15.2 Option B [15.2.1 to 15.2.5] 15.2.1 Immediately transfer the Carb xen 572 arti les and the glass fibre filter pad into the vial or flask [6.9]. 15.2.2 Add slowly 10 mL (for linear) 20 mL (for rotary) of solvent mixture [9.2.2] into the vial or flask. Close the vial or flask i mediately. 15.2.3 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles or rounds per min. 15.2.4 Let the sample stand for at least one minute (or until the particles settle). 15.2.5 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 16. SAMPLE ANALYSIS This method utilizes gas chromatograph coupled with GC-MS to quantify benzene and 1,3-butadiene in mainstream cigarette smoke. The analytes are resolved from other potential interference on the column used. Comparison of the area ratio (native analyte area/isotope-labelled analyte area) of the unknowns with the concentration of known standard concentrations yields individual analyte concentrations. 16.1 Gas chromatography and mass spectrometer operating conditions 16.1.1 Gas chromatography conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 2 Table 3. This section illustrates an example of GC equipment and its operating conditions. GC Column InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences Injector temperature: 240 oC (iontrap: 200 °C) Mode: Constant flow Flow rate: 1.0 mL/min (iontrap 1.0 mL/min) Injection: 1 µL or 2 µL with split ratio 1:10 (Ion trap 1:5 after 1.5 mins 1:120) Column temperature: 40 °C for 6 mins 6 °C/min to 250 °C Total run time 45 mins Interface/Transfer line temperature: 180 °C (iontrap 200 °C) • For the conditions described here, the expected sequence of elution will be 1,3-butadiene, carbon disulfide, benzene-d6 and benzene. • It is expected that differences, such as in flow rate, mobile phase concentration, age of the column, will alter retention times. • The elution order and retention times must be verified before analysis is begun. • Using the above conditions, the expected total analysis time will be about 60 minutes. Note: Adjustment of the op rating parameters may be required, depending on the instrument and column conditions as well as the resolution of the chromatographic peaks. 16.1.2 Mass spectrometer conditions and peak identification Table 4. The acquisition of the m/z signals is performed in full scan mode: Ion source: 200 °C ( ion trap 180°C) Dwell time 50 msec Ionization mode: Electron Ionization (ionizing voltage at 70 eV) Detection: Full-scan m/z 30-300 Ion peak for identification Benzene : m/z 78 Benzene – d6: m/z 84 1,3-Butadiene: m/z 54 16.2 VOCs Determination 16.2.1 Condition the system just prior to use by injecting two 1 µl or 2 µl aliquots of a sample solution as a primer. 16.2.2 Inject a check standard (blank with internal standard) under the same conditions as the samples to verify the performance of the GC-MS system. 16.2.3 Inject a blank (extraction solution) to check any contamination in the system or extraction solution or reagents. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 22 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 16.2.4 Inject an aliquot of each working standard solution into the GC-MS. 16.2.5 Assess the retention times and relative response ratio (based on area counts) for the labelled standards. If the retention times are similar (± 0.2 min) to the retention times and relative response ratio are within ± 20% of the typical responses from the previous runs, the system is ready to perform the analysis. 16.2.6 Inject the calibration standards, quality controls (QCs), and samples and determine peak areas and relative response ratio using the instrument software. 16.2.7 Record the peak areas of benzene, 1,3-butadiene and benzene-d6. 16.2.8 Calculate the ratio of the Benzene peak to the internal standard peak (RF = ABenzene/ABenzene-d6) for each of the Benzene and 1,3-butadiene standard solutions including the standard blanks. 16.2.9 Plot the graph of the concentration of added benzene (X axis) in accordance with the area ratios (Y axis). 16.2.10 The intercept should not be statistically significantly different from zero. 16.2.11 Linearity of the standard curve should extend over the entire standard range. 16.2.12 Calculate the linear regression (Y = a + bx) from these data, and use both the slope (b) and the intercept (a) of the inear regression. If the linear regression R2 is less than 0,99, the calibration should be repeated. If an individual calibration point differs by more than 10% from the expected value (estimated by linear regression), this point should be omitted. 16.2.13 Inject the QCs and samples and determine peak areas using the instrument software. 16.2.14 The relative response factors (peak area ratio) obtained for all test portions must fall within the working range of the calibration curve. Note: See Appendix 1 for representative chromatograms. 17. DATA ANALYSIS AND CALCULATIONS The slope and intercept are determined from the relative responses of the analyte and the labelled standard versus the relative concentrations of the analyte and the labelled standard. 17.1 Calculate the relative response ratio from the peak areas for each of the volatile organics for each of the calibration standards [10.2.3]: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 23 where: RF = relative response ratio Aa= area of the target analyte AIS= area of the corresponding internal standard. Plot a graph for each of the volatile organics, of the relative response factor, Aa /AIS , (Y axis) versus concentration (X axis). Calculate a linear regression equation (RF = kX + m) from these data, and use both the slope (k) and the intercept (m) of the linear regression. 17.2 The linearity of the standard curve should cover the entire standard range. 17.3 The content MVOCs of a given volatile organics of the target analyte (µg/ cigarette) is determined from he calculated rel tive response ratio for the test portion, the slope and intercept obtained from the appropriate calibration curve, and the equation: where: MVOCs = calculated content, in µg/cigarette V = volume of extraction solution (10 ml or 20 mL) N = 1 (number of cigarette smoked onto each cartridge). RF = Relative response ratio m = intercept of the Y-axis of the calibration curve k = slope of the calibration curve Alternative calculation procedures may be used if applicable. 18. SPECIAL PRECAUTIONS After installing a new colum , condition it as specified by the manufacturer by injecting a tobacco sample extract under the specified instrument conditions. Injections should be repeated until the peak areas (or heights) of each of the volatile organics and the internal standards are reproducible. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 24 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19. DATA REPORTING 19.1 Report individual measurements for each of the samples evaluated. 19.2 Report results as specified by method specifications. 19.3 For more information, see WHO TobLabNet SOP 02 [2.7]. 20. QUALITY CONTROL 20.1 Control parameters Note: If the control me surements ar outside th tolerance limits of the expected values, appropriate investigation and action must be taken. Note: Additional laboratory quality assurance procedures should be carried out in compliance with the policies of the individual laboratory. 20.2 Laboratory reagent blank To detect potential contamination during sample preparation and analysis, include a laboratory reagent blank, as described in [16.2.3]. The blank consists of all reagents and materials used in analysing test samples, including the extraction of CX-572 and glass fibre filter pad, and is analysed like a test sample. The assessment of the blank should be less than the limit of detection. 20.3 Quality control sampl To verify the consistency f the entir analy ical process, analyse a reference cigarette in accordance with the practices of the individual laboratory. 20.4 Additional QC Additional QC samples may be added as consistent with laboratory policy. 21. METHOD PERFORMANCE SPECIFICATIONS 21.2 Limit of Report (LOR) The LOR is set to the lowest concentration of the calibration standards used, recalculated to ng/cigarette (0.05 µmol/mL as the lowest calibration solution). 21.2 Laboratory fortified matrix recovery Recovery of analyte spiked onto the matrix is used as a surrogate measure of accuracy. Recovery is determined by spiking known amounts of standards (after smoking) and extracting by the same method as used for samples. Unspiked samples are also analysed. The recovery is calculated from the following formula and as shown in Table 5 below: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 25 Recovery = 100 × (analytical result – unspiked result/spiked amount) Table 5. Mean and recovery spiked onto the matrix (to be added after the completion of the validation) Benzene 1,3-butadiene Spiked amount (µg) Mean (mg) Recovery (%) Spiked amount (µg) Mean (mg) Recovery (%) 16.9 18.4 108.9 10 9.4 94.0 33.8 37.0 109.5 20 18.6 93.0 67.6 75.2 111.2 40 41.9 104.8 21.4 Analytical specificity GC-MS provides excellent analytical specificity. The retention time, the confirmation ion ratio, an established range of ratios of the response of the quantification ion to that of the confirmation ion and quality control samples are used to verify the specificity of the results for an unknown sample. 21.5 Linearity The volatile organics calibration curves established are linear over the standard concentration range of 0.5–200 ng/mL. 21.6 Possible interference There are no known components that can cause an interference by having both a similar retention time and confirmation ion pair ratio as volatile organics or the internal standards. 22. REPEATABILITY AND REPRODUCIBILITY An international collaborative study conducted from 2015–2017, involving 10 laboratories and five samples (three reference cigarettes and two commercial brands), performed according to WHO TobLabNet SOP 02 (2.7) gave the following precision limits for this method. The difference between two single results found on matched cigarette samples by the same operator using the same apparatus within the shortest feasible time interval will exceed the repeatability, r, on average not more than once in 20 cases in the normal and correct operation of the method. Single results on matched cigarette samples reported by two laboratories will differ by more than the reproducibility, R, on average not more than once in 20 cases in the normal and correct operation of the method. The test results were analysed statistically in accordance with ISO 5725-1 [2.10] and ISO 5725-2 [2.5] to give the precision data shown in Tables 6–7. For the purpose of calculating r and R, one test result under ISO smoking conditions was defined as the average of seven individual replicates of the mean yield of three smoke traps (one cigarette smoked per smoke trap) from linear smoking machines and World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 26 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions three smoke traps for rot ry smoking machines. Under i tense smoking conditions, one test result was defined as the average of seven individual replicates of the mean yield of three smoke traps fr m li ear smoking machines and three smoke traps for rotary smoking machines. For mor information, see reference [2.6]. Table 6a and 6b. Precision limits for determination of 1,3-butadiene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette 1,3-butadiene: ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 11.06 1.96 4.27 3R4F 9 39.23 7.20 16.34 CM6 6 60. 6 1.74 2.18 Commercial Brand I 8 72.71 8.03 42.79 Commercial Brand II 8 61.58 9.97 16.80 Reference cigarette 1,3-butadiene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 7 82.26 8.11 8.63 3R4F 8 92.22 11.51 13.18 CM6 7 106.20 12.59 12.67 Commercial Brand I 8 153.96 17.20 70.04 Commercial Brand II 6 141.52 11.00 14.55 Table 7a and 7b. Precision limits for determination of Benzene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette benzen : ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 9 13.47 2.54 6.46 3R4F 9 44.50 6.94 10.15 CM6 8 72.86 5.94 11.40 Commercial Brand I 9 58.78 6.54 15.18 Commercial Brand II 9 49.94 8.83 15.37 Reference cigarette benzene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 85.59 8.17 16.68 3R4F 9 95.95 8.49 40.92 CM6 8 108.35 6.93 23.52 Commercial Brand I 8 122.00 7.21 48.76 Commercial Brand II 8 111.77 6.60 36.32 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 27 Appendix 1. Typical chromatograms obtained in the determination of volatile organics in mainstream cigarette smoke Fig. A1. Representative chromatogram of standard 21 Total ion chromatogram of a mixed standard solution. BD, 1,3-butadiene; BZ- d6, benzene-d6; BZ, benzene Fig. A2. Representative chromatogram of volatile organics in cigarette mainstream smoke2 Total ion chromatogram of a sample solution. BD, 1,3-butadiene; BZ-d6, benzene-d6; BZ, benzene 1 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. 2 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 28 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Appendix 2: Smoking Plans The described smoking plans are based on five different samples (cigarettes brand/ types) and seven replicates per sample. If a different number of sa ples or replicates is needed the plans should be adjusted accordingly. Smoking plan for 20-port linear smoking machine (one cigarette per cartridge) D ay Port number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 A B C D E A B C D E A B C D E 2 D E A B C D E A B C D E A B C 3 B C C D E A B C D E A B D E A 4 E A B C D E A B C D E A B C D 5 C D E A B C D E A B C D E A B 6 D C B A E D C B A E D C B A E 7 C B A E D C B A E D C B A E D Smoking plan for rotary smoking machine (one cigarette per cartridge) Day Run Sample Day Run Sample Day Run Sample Day Run Sample World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 29 1 1 A 3 31 B 5 61 C 7 91 C 2 A 32 B 62 C 92 C 3 A 33 B 63 C 93 C 4 B 34 C 64 D 94 B 5 B 35 C 65 D 95 B 6 B 36 C 66 D 96 B 7 C 37 D 67 E 97 A 8 C 38 D 68 E 98 A 9 C 39 D 69 E 99 A 10 D 40 E 70 A 100 E 11 D 41 E 71 A 101 E 12 D 42 E 72 A 102 E 13 E 43 A 73 B 103 D 14 E 44 A 74 B 104 D 15 E 45 A 75 B 105 D 2 16 D 4 46 E 6 76 D 17 D 47 E 77 D 18 D 48 E 78 D 19 E 49 A 79 C 20 E 50 A 80 C 21 E 51 A 81 C 22 A 52 B 82 B 23 A 53 B 83 B 24 A 54 B 84 B 25 B 55 C 85 A 26 B 56 C 86 A 27 B 57 C 87 A 28 C 58 D 88 E 29 C 59 D 89 E 30 C 60 D 90 E This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions.

WHO TobLabNet Official Method SOP 09 Standard Operating prOcedure fOr determinatiOn Of VOlatile OrganicS in mainStream cigarette SmOke under iSO and intenSe SmOking cOnditiOnS Tobacco Free Initiative Tobacco Laboratory Network (TobLabNet) World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3 WHO TobLabNet Official Method SOP 09 Standard operating pr cedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 4 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Standard operating procedure for etermination of volatile organics in ainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09 ISBN 978-92-4-151477-4 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions, WHO TobLabNet Official Method SOP09. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine w ther permission is needed for that reuse a d to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Printed in Switzerland World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 5 No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: Benzene (CAS# 71-43-2) 1,3-butadiene (CAS# 106-99-0) Matrix: Tobacc cigarette mainstream smoke particulate matter Last update: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 6 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions No machine smoking regimen an represent all human smoking behaviour: machine smoking testing is useful for characterizing cigarette emissions for des gn and regulatory purp ses, but communication of machine measurements to smokers can result in misunderstanding about differ nces b tween brands in exposure and risk. Data on smoke emissions from machine measurements may be used as inputs for product hazard assessment, but they are not intended to be nor are they valid as measur of human exposure or risks. Representing differences in machine measurements as differences in exposure or risk is a misuse of testing w th WHO TobLabNet standards. No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 7 FOREWORD This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for measuring volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions. INTRODUCTION In order to establish comparable measurements for testing tobacco products globally, consensus methods are required for measuring specific contents and emissions of cigarettes. The Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (WHO FCTC) at its third session in Durban, South Africa, in November 2008, recalling its decisions FCTC/COP1(15) and FCTC/COP2(14) on the elaboration of guidelines for implementation of Articles 9 (Regulation of the contents of tobacco products) and 10 (Regulation of tobacco product disclosures) of the WHO FCTC, noting the information contained in the report of the working group to the third session of the Conference of the Parties on the progress of its work … requested the Convention Secretariat to invite WHO’s Tobacco Free Initiative to “validate, within five years, the analytical chemical methods for testing and measuring cigarette contents and emissions”.1 Using the criteria for prioritization set at its third meeting in Ottawa, Canada, in October 2006, the working group on Articles 9 and 10 identified the following contents for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • nicotine • ammonia • humectants (propane-1,2-diol, glycerol (propane-1,2,3-triol) and triethylene glycol (2,2-ethylenedioxybis(ethanol)). Measurement of these contents will require validation of three methods: one for nicotine, one for ammonia and one for humectants. Using the criteria for prioritiz ti set at the meeting i Ottawa m ntioned above, the working group ident fied the following emissions in mainstream smoke for which methods for testing and measurement (analytical chemistry) should be validated as a priority: • 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) • N-nitrosonornicotine (NNN) 1 Decision, third session of the Conference of the Parties to the WHO FCTC; 2008 (http://apps.who. int/gb/fctc/PDF/cop3/FCTC_COP3_REC1- n.pdf). No.: SOP 09 Date: 31 August 2018 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 8 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions • acetaldehyde • acrylaldehyde (acrolein) • benzene • benzo[a]pyrene • 1,3-butadiene • carbon monoxide • formaldehyde Measurement of these emissions with the two smoking r gimens described below will require validation of four methods: one for tobacco-specific nitrosamines (NNK and NNN), one for benzo[a]pyrene, one for aldehydes (acetaldehyde, acrolein and formaldehyde), one for volatile organic compounds (benzene, 1,3-butadiene) and one for carbon monoxide. The table below sets out the two smoking regimens for validation of the test methods referred to above. Smoking regimen Puff volume (mL) Puff frequency Filter ventilation holes ISO regimen: ISO 3308; Routine analytical cigarette smoking machine—definitions and standard conditions 35 Once every 60 s No modifications Intense regimen: Same as ISO 3308, but modified as indicated 55 Once every 30 s All ventilation holes must be blocked 100% as described in WHO TobLabNet SOP 01. This method SOP was developed to direct participating labs in the specifics of carrying out the analysis of volatile organic components in mainstream cigarette smoke. For tobacco products other than cigarettes, specific parameters may have to be adjusted from those given in the document 1. SCOPE This method is suitable for quantitative determination of the following two volatile organics in mainstream cigarette smoke: benzene and 1,3-butadiene by combined gas chromatography mass spectrometry. Benzene and 1,3-butadiene are potent carcinogens. Benzene and 1,3-butadiene are not originally present in tobacco leaves but are formed from the combustion of organic material during cigarette burning. Note: Training in the use of the smoking machine and other analytical equipment is important for successful operation. For those not experienced in operating smoking machines or analyses using the analytical methods for measuring tobacco product emissions and contents, training should be obtained. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 9 2. REFERENCES 2.1 ISO 3308: Routine analytical cigarette-smoking machine – Definitions and standard conditions. Geneva: International Organization for Standardization; 2012. 2.2 ISO 4387: Cigarettes—Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. Geneva: International Organization for Standardization; 2000. 2.3 ISO 3402: Tobacco and tobacco products—Atmosphere for conditioning and testing. Geneva: International Organization for Standardization; 1999. 2.4 ISO 8243: Cigarettes—Sampling. Geneva: International Organization for Standardization; 2006. 2.5 ISO 5725-2: Accuracy (trueness and precision) or measurement methods and results—Part 2: Basic method for the determination of repeatability and reproducibility of a standard measurement method. 2.6 Tobacco Laboratory Network, Standard Operating Procedure for Intense Smoking (WHO TobLabNet SOP 01). ). Geneva: World Health Organization; 2012 (http:// apps.who.int/iris/bitstream/handle/10665/75261/9789241503891_eng. pdf;sequence=1, accessed 3 September 2018). 2.7 Tobacco Laboratory Network. Standard operating procedures for validation of alytical methods of tobacco product contents and emissions (WHO TobLabNet SOP 02). Geneva: World Health Organization., 2012 (http://apps. who.int/iris/bitstream/handle/10665/254998/9789241512060-eng. pdf?sequence=1, accessed 3 September, 2018). 2.8 Tobacco Laboratory Network. Standard Operating Procedure for the Determination of aldehydes in mainstream cigarette smoke under ISO and intense smoking conditions (WHO TobLabNet SOP 08). Geneva: World Health Organization; (jn press). 2.9 United Nations Office on Drugs and Crime. Guidelines on representative drug sampling. Vienna: Laboratory and Scientific Section; 2009 (http://www.unodc. org/documents/scientific/Drug_Sampling.pdf). 2.10 ISO 5725-1. Accuracy (trueness and precision) of measurement methods and results—Part 1: General principles and definitions. Geneva: International Organization for Standardization; 1994. 2.11 Uchiyama, S.; Tomizawa, T.; Inaba, Y.; Kunugita, N. Simultaneous determination of volatile organic comp unds and carbonyls i mainstream cigarette smoke using a sorbent cartridge followed by two-step elution. J Chromatogr A, 2013. 1314:31-7. doi: 10.1016/j.chroma.2013.09.019. 2.12 Uchiyama, S.; Haya hida, H.; Izu, R.; Inaba, Y.; Nakagome, H.; Kunugita, N. Determination of nicotine, tar, volatile organic compounds and carbonyls in mainstream cigarette smoke using a glass filter and a sorbent cartridge followed by the two-phase / one-pot elution method with carbon disulfide and methanol. Journal of Chromatography A 2015. 1426:48-55. doi.org/10.1016/j. chroma.2015.11.058. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 10 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 3. TERMS AND DEFINITIONS CX-572: Carbon molecular sieves Carboxen 572 Intense Regime: Parameters for smoking tobacco products that include a 55-ml puff volume, a 30 s puff interval, 2 s puff duration and 100% blocking of filter ventilation hole ISO regime: Parameters for smoking tobacco pr ducts t at include a 35-ml puff volume, a 60 s puff interval, 2 s puff duration and no blocking of filter ventilation hole Laboratory sample: Sample intended for testing in a laboratory, consisting of a single type of product delivered to the laboratory at one time or within a specified period. Smoke trap: device for collecting such pa t of the smoke fr m a s mple of cig rettes as is necessary for the determination of specified smoke components. Test portion: Random portion from the test sample to be used for a single determination. The number of products taken shall be representative of the test sample. Test sample: Product to be tested, taken at random from the laborat ry sample. Th number of products taken shall be representative of the laboratory sample. Tobacco products: Products entirely or partly made of the leaf tobacco as raw material which are manufactured to be used for smoking, sucking, chewing or snuffing (Article 1(f) of the WHO FCTC) TPM: total particulate matter 4. METHOD SUMMARY 4.1 Mainstream cigarette smoke is performed according to the WHO Intense regime or the ISO regime. One cigarette is smoked per smoke trap containing 300 mg CX-572 particles and a glass fibre filter pad. 4.2 Mainstream smoke total particulate matter from the cigarette test sample is trapped onto a smoke trap containing 300 mg CX-572 particles and a glass- fibre filter pad (commonly referred to as a glass fibre filter pad). 4.3 The volatile organic components are extracted by adding a solution containing a mixture of carbon disulphide and methanol onto the Carboxen particles and glass fibre filter pad. 4.4 The analytical determination of VOCs (1,3-butadiene and benzene) is performed by gas chromatography–mass spectrometry (GC-MS) with electron ionization mode. 4.5 The reconstructed ion chromatogram peak area ratio of native analyte to labelled internal standard is compared on a calibration curve created by analysis of standards with known concentrations of the benzene and 1,3-butadiene to determine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 1 4.6 The benzene and 1,3-butadiene content of each test portion. 4.7 The method described in this SOP simultaneously tests and measures the level of aldehydes (SOP 08) and volatile organics (SOP 09) produced in mainstream cigarette smoke. 5. SAFETY AND ENVIRONMENTAL PRECAUTIONS 5.1 Follow routine safety and environmental precautions, as in any chemical laboratory activity. 5.2 The testing and evaluation of certain products with this test method may require the use of materials or equipment that could be hazardous or harmful to the environment; this document does not purport to address all the safety aspects associated with its use. All persons using this method have the responsibility to consult the appropriate authorities and to establish health and safety practices as well as environmental precautions in conjunction with any existing applicable regulatory requirements prior to its use. 5.3 Special care should be taken to avoid inhalation or dermal exposure to harmful chemicals. Use a chemical fume hood, and wear an appropriate laboratory coat, gloves and safety goggles when preparing or handling undiluted materials, standard solutions, extraction solutions or collected samples. 6. APPARATUS AND EQUIPMENT 6.1 Equipment needed to condition cigarettes as specified in ISO 3402 [2.3]. 6.2 Equipment needed to mark butt length as specified in ISO 4387 [2.2]. 6.3 Equipment needed to cover filter ventilation holes for the intense regimen as specified in WHO TobLabNet SOP 01 [2.6]. 6.4 Equipment needed to perform smoking of cigarette products as specified in ISO 3308 [2.1]. 6.5 Analytical balance capable of measurements to at least four decimal places. 6.6 Pipettes and tips capable of accurately dispensing volumes of 5–5000 μl. 6.7 Teflon-lined septa or equivalent. 6.8 Volumetric flasks 5 mL, 10 mL, 50 mL or equivalent. 6.9 Vials with septum seal, capacity of at least 20 mL (linear) or 50 mL (rotary) or equivalent. 6.10 Syringe, 1 mL and 5 mL or equivalent for transfer of organic solvent. 6.11 GC autosampler vials, 2 mL or equivalent. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 12 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 6.12 GC coupled with mass spectrometer det ctor. 6.13 GC column capable of distinct separation of benzene, 1,3-butadiene and isotopically labelled benzene peaks from other cigarette emission components, e.g. InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences or equivalent. 6.14 Carboxen 572 particles, 20/45 mesh size. 6.15 CX-572 cartridge: either manually prepared SPE cartridge filled with 300 mg of Carboxen 572 particles or preloaded CX-572 cartridge acquired by Sigma Aldrich (Cat. No. 54294-U). 6.16 Glass fibre filter pad as described in ISO 4387 [2.2] 6.17 Smoke trap set up consists of smoking machine holders attached with CX-572 (with or without cartridge) to be placed in front of glass fibre filter pad. (See Figs. 1 to 5). Note: Place the CX-572 cartridge in the holder facing the open side towa ds the cigarette. When positioned with the open end in the opposite direction, the content of the cartridge can be sucked into the smoking machine when puffs are taken. If necessary, special stopper can be inserted into the cartridge as shown in Fig. 6. Fig. 1a: Single port Borgwaldt Smoking Machine World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 13 Fig. 1b: Linear Borgwaldt smoking machine Fig. 2a and Fig. 2b illustrate the cigarette holder suitable for use in commercial rotary smoking machine (i.e. Cerulean and/or Borgwaldt smoking machine) Fig. 2a: with the CX-572 particles weigh directly onto he holder Fig. 2b: with the CX-572 loaded cartridge inserted onto the holder Fig. 3: For Linear Cerulean smoking machine (also applicable to Linear Borgwaldt smoking machine) Note: CX-572 can be pre-packed into this holder or alternatively, a commercially available CX-572 cartridge can be used. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 14 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Fig. 4: For Linear Cerulean smoking m chine (also applicable to Linear B rgwaldt or Rotary Cerul an or single channel smoking machine) Fig. 5: For Linear Cerulean smoking m chine (also applicable to Linear Borgwaldt smoking machine) Fig. 6: Stoppers to be inserted into the CX-572 cartridges to prevent the contend to be sucked into the smoking machine Note: Be sure to put the cartridge into a closed vessel (vial) directly after inserting the stopper to prevent contamination of the CX-572. 7. REAGENTS AND SUPPLIES All reagents shall be of at least analytical reagent grade unless otherwise noted. When possible reagents are identified by their Chemical Abstract Service (CAS) registry numbers. 7.1 Benzene, analytical-grade. CAS number: 71-43-2. 7.2 Deuterium-labelled benzene (benzene-d6) purity>99%. CAS number: 1076- 43-3. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15 7.3 1,3-butadiene standard solution (2 mg/ml) [CAS number:106-99-0]. (AccuStandard, S-406A-10X). 7.4 Carbon disulfide, analytical-grade. CAS number: 75-15-0. 7.5 Methanol, anhydrous, analytical-grade. CAS number: 67-56-1. 7.6 Carboxen 572 particles, 20/45 mesh size (Sigma-Aldrich/Supelco Cat. No. 11072-U). 8. PREPARATION OF GLASSWARE Clean and dry glassware in a manner to avoid contamination from residues. 9. PREPARATION OF SOLUTIONS 9.1 Isotopically labelled internal standard solution (benzene-d6 5 mg/mL) 9.1.1 Weigh accurately 500 mg of benzene-d6 into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 9.1.2 Label and store at -20 oC ± 5 oC. 9.2 Extraction solution: The extraction solutions can be prepared with the following two options: 9.1.1 Option A: Carbon disulfide and methanol. 9.1.2 Option B: Carbon disulfide and methanol (1:4) mixed solution containing internal standard solution. Add 20 mL of carbon disulfide and 500 µL or 250 µL of internal standard solution (benzene-d6 5 mg/mL) to the 100 mL volumetric flask and dilute with methanol. The internal standard concentration of benzene-d6 is 25 µg/mL for linear or 12.5 µg/mL for rotary. 9.1.3 Carbon disulfide and methanol (1:4) mixed solution. Add 20 mL of carbon disulfide to the 100 mL volumetric flask and dilute with m thanol. Note: The amount of extraction solution prepared can be adjusted based on the need of the analysis. The following are for illustrative purposes only. 10. PREPARATION OF STANDARDS Note: can be adjusted accordingly with the condition that the standard range and internal standards concentration remains the same 10.1 VOCs (benzene 80 μg/mL and 1,3-butadiene 200 μg/mL) stock solutions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 16 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 10.1.1 Benzene 2.0 mg/mL standard solutio . Weigh accurately 200 mg of benzene [7.1] into a 100 mL volumetric flask added with ca. 80 mL methanol. Dilute to 100 mL with methanol. 10.1.2 Pipette 0.8 mL of the benzene standard solution [10.1] a d 2.0 mL of the 1,3-butadiene standard solution [7.3] into a 20 mL volumetric flask. 10.1.3 After addition of 4 mL of CS2 [7.4], the solution is diluted to 20 mL with methanol [7.5]. 10.1.4 Label and store at 4 °C ± 3 °C in amber vials. 10.2 VOCs working standard solutions 10.2.1 Depending on type of smoking machi e used, pipette variable volumes of the stock solution [10.1] and solvent mixture [9.2.3] into gas chromatography (GC) autosampler vials according to Table 1a (linear) or 1b (rotary). 10.2.2 Add isotopically labelled internal standard [9.1] according to Table 1a (linear) or 1b (rotary) and mix well. 10.2.3 Label and store at 4 °C ± 3 °C. Table 1a (option A). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 100 0 0 2 0.50 5 100 8 20 3 1.00 5 100 16 40 4 1.50 5 100 24 60 5 2.00 5 100 32 80 6 4.00 5 100 64 160 Table 1b (option A). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is added to each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] Total volume (mL) Addition of internal standard (µl) [9.1] concentration (mg/L) Benzene 1,3-Butadiene 1 0 5 50 0 0 2 0.25 5 50 4 10 3 0.50 5 50 8 20 4 0.75 5 50 12 30 5 1.00 5 50 16 40 6 2.00 5 50 32 80 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 17 Table 1c (option B). Linear smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 20 5 0 0 2 0.50 20 5 8 20 3 1.00 20 5 16 40 4 1.50 20 5 24 60 5 2.00 20 5 32 80 6 4.00 20 5 64 160 Table 1d (option B). Rotary smoking machine: concentrations of VOCs in working standard solutions. Internal standard is involved in each 5 mL standard solution. Standard VOCs stock solution (mL) [10.1] internal standard (µl) [9.1] Total volume (mL) Approximate VOCs concentration (mg/L) Benzene 1,3-Butadiene 1 0.00 10 5 0 0 2 0.25 10 5 4 10 3 0.50 10 5 8 20 4 0.75 10 5 12 30 5 1.00 10 5 16 40 6 2.50 10 5 40 100 The range of the working standard solutions may be adjusted depending on the equipment used and samples to be tested, keeping in mind the possible influence on the sensitivity of the applied method. All solvents and solutions must be adjusted to room temperature before use. 11. SAMPLING 11.1 Sample cigarettes according to ISO 8243 [2.4]. Alternative approaches may be used to obtain a representative laboratory sample in accordance with individual laboratory practice or when required by specific regulation or the availability of samples. 11.2 Constitution of test sample 11.2.1 Divide the laboratory sample into separate units (e.g. packet, container), if applicable. 11.2.2 Take an equal amount of product for each test sample from at least √n [2.9] of the individual units (e.g. packet, container). Note: Arbitrary sampling method is applied. √n is one of the method often used in practice and work well in many situations [2.9]. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 18 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 12. CIGARETTE PREPARATION 12.1 Condition all cigarettes to be smoked in accordance with ISO 3402 [2.3]. 12.2 Mark cigarettes at a butt length in accordance with ISO 4387 [2.2] and WHO TobLabNet SOP 01 [2.6]. 12.3 Prepare test samples to be smoked under Intense smoking conditions as specified in WHO TobLabNet SOP 01 [2.6]. 13. PREPARATION OF THE SMOKING MACHINE 13.1 Ambient conditions The ambient conditions for smoking are specified in ISO 3308 [2.1]. 13.2 Smoking machine specifications Follow ISO 3308 [2.1] machin specifications, except for int nse smoking, as described in WHO TobLabNet SOP 01 [2.6]. Prepare the smoke trap as described above [6.17] so that they are consistent with Figs. 1 to 5. 14. SAMPLE GENERATION 14.1 Smoke the cigarette test samples, as specified in ISO 4387 [2.2] or in WHO TobLabNet SOP 01 [2.6] and collect the volatile organic compounds of the mainstream smoke nto the smoke tr p [6.17] c ntaining th CX-572 cartridge [6.15] and glass fibre filter pad [6.16]. 14.2 Include at least one reference test sample to be used for quality control, if applicable. 14.3 The number of cigarettes to be smoked per measurement for linear and rotary smoking machines at ISO and intense smoking regimens are shown in Table 2. Table 2. Number of cigarettes to be smoked for one measurement in linear and rotary smoking machines. Refer to Appendix 4 for the appropriate smoking plan. ISO smoking regimen Intense smoking regimen Linear Rotary Linear Rotary No. of cigarettes per smoke trap 1 1 1 1 No. of smoke traps per result 3 3 3 3 Note: Smoke 1 cigarette on the specified smoking machine such that breakthrough does not occur and the concentrations of benzene and 1,3- butadiene fall within the calibration range prepared for the analysis. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19 14.4 Record the number of cigarettes and total puffs for each smoke trap. 14.5 After smoking the required number of test samples, perform one clearing puff, and remove the smoke trap from the smoking machine. 14.6 One result is an average of three measurements. 14.7 Blank measurement is made on 10 puffs at least once per day before smoking cigarette samples. Fig. 7: Overview of the analytical procedure for simultaneous determination of aldehydes (SOP 08) and volatile organics (SOP 09) in mainstream cigarette smoke 15. SAMPLE PREP RATION Extraction (there are two options: individually add CS2 followed by MeOH (option A) or using a mixture of extraction solution (option B). World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 20 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 15.1 Option A (15.1.1 to 15.1.7) 15.1.1 Add 2 mL (for linear) or 4 mL (for rotary) of carbon disulfide [7.4] into the vial or flask [6.9]. Slowly add 8 mL (for linear) or 16 mL (for rotary) of methanol. DO NOT MIX the two solutions. CX-572 is added quickly into the two-phase solution. 15.1.2 After bubbling stop, swirl gently and place the glass fibre filter pad into the vial or flask. 15.1.3 Close the vial or flask. 15.1.4 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles per min. 15.1.5 Let the sample stand for at least one minute (or until the particles settle). 15.1.6 Transfer 5 mL of the supernatant solution into a vial and add 100 µl (for linear) or 50 µl (f r r tary) of int rnal standard solution [9.1]. 15.1.7 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 15.2 Option B [15.2.1 to 15.2.5] 15.2.1 Immediately transfer the Carb xen 572 arti les and the glass fibre filter pad into the vial or flask [6.9]. 15.2.2 Add slowly 10 mL (for linear) 20 mL (for rotary) of solvent mixture [9.2.2] into the vial or flask. Close the vial or flask i mediately. 15.2.3 Shake the mixture gently on a rotary shaker for 30 mins at 120 cycles or rounds per min. 15.2.4 Let the sample stand for at least one minute (or until the particles settle). 15.2.5 After mixed, transfer a 1 mL portion of the eluate solution to a 1.5 mL autosampler vial [6.10] and analyse the solution by GC/MS. 16. SAMPLE ANALYSIS This method utilizes gas chromatograph coupled with GC-MS to quantify benzene and 1,3-butadiene in mainstream cigarette smoke. The analytes are resolved from other potential interference on the column used. Comparison of the area ratio (native analyte area/isotope-labelled analyte area) of the unknowns with the concentration of known standard concentrations yields individual analyte concentrations. 16.1 Gas chromatography and mass spectrometer operating conditions 16.1.1 Gas chromatography conditions World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 2 Table 3. This section illustrates an example of GC equipment and its operating conditions. GC Column InertCap AQUATIC-2 60 m x 0.25 mm i.d., d=1.4 µm by GL Sciences Injector temperature: 240 oC (iontrap: 200 °C) Mode: Constant flow Flow rate: 1.0 mL/min (iontrap 1.0 mL/min) Injection: 1 µL or 2 µL with split ratio 1:10 (Ion trap 1:5 after 1.5 mins 1:120) Column temperature: 40 °C for 6 mins 6 °C/min to 250 °C Total run time 45 mins Interface/Transfer line temperature: 180 °C (iontrap 200 °C) • For the conditions described here, the expected sequence of elution will be 1,3-butadiene, carbon disulfide, benzene-d6 and benzene. • It is expected that differences, such as in flow rate, mobile phase concentration, age of the column, will alter retention times. • The elution order and retention times must be verified before analysis is begun. • Using the above conditions, the expected total analysis time will be about 60 minutes. Note: Adjustment of the op rating parameters may be required, depending on the instrument and column conditions as well as the resolution of the chromatographic peaks. 16.1.2 Mass spectrometer conditions and peak identification Table 4. The acquisition of the m/z signals is performed in full scan mode: Ion source: 200 °C ( ion trap 180°C) Dwell time 50 msec Ionization mode: Electron Ionization (ionizing voltage at 70 eV) Detection: Full-scan m/z 30-300 Ion peak for identification Benzene : m/z 78 Benzene – d6: m/z 84 1,3-Butadiene: m/z 54 16.2 VOCs Determination 16.2.1 Condition the system just prior to use by injecting two 1 µl or 2 µl aliquots of a sample solution as a primer. 16.2.2 Inject a check standard (blank with internal standard) under the same conditions as the samples to verify the performance of the GC-MS system. 16.2.3 Inject a blank (extraction solution) to check any contamination in the system or extraction solution or reagents. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 22 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 16.2.4 Inject an aliquot of each working standard solution into the GC-MS. 16.2.5 Assess the retention times and relative response ratio (based on area counts) for the labelled standards. If the retention times are similar (± 0.2 min) to the retention times and relative response ratio are within ± 20% of the typical responses from the previous runs, the system is ready to perform the analysis. 16.2.6 Inject the calibration standards, quality controls (QCs), and samples and determine peak areas and relative response ratio using the instrument software. 16.2.7 Record the peak areas of benzene, 1,3-butadiene and benzene-d6. 16.2.8 Calculate the ratio of the Benzene peak to the internal standard peak (RF = ABenzene/ABenzene-d6) for each of the Benzene and 1,3-butadiene standard solutions including the standard blanks. 16.2.9 Plot the graph of the concentration of added benzene (X axis) in accordance with the area ratios (Y axis). 16.2.10 The intercept should not be statistically significantly different from zero. 16.2.11 Linearity of the standard curve should extend over the entire standard range. 16.2.12 Calculate the linear regression (Y = a + bx) from these data, and use both the slope (b) and the intercept (a) of the inear regression. If the linear regression R2 is less than 0,99, the calibration should be repeated. If an individual calibration point differs by more than 10% from the expected value (estimated by linear regression), this point should be omitted. 16.2.13 Inject the QCs and samples and determine peak areas using the instrument software. 16.2.14 The relative response factors (peak area ratio) obtained for all test portions must fall within the working range of the calibration curve. Note: See Appendix 1 for representative chromatograms. 17. DATA ANALYSIS AND CALCULATIONS The slope and intercept are determined from the relative responses of the analyte and the labelled standard versus the relative concentrations of the analyte and the labelled standard. 17.1 Calculate the relative response ratio from the peak areas for each of the volatile organics for each of the calibration standards [10.2.3]: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 23 where: RF = relative response ratio Aa= area of the target analyte AIS= area of the corresponding internal standard. Plot a graph for each of the volatile organics, of the relative response factor, Aa /AIS , (Y axis) versus concentration (X axis). Calculate a linear regression equation (RF = kX + m) from these data, and use both the slope (k) and the intercept (m) of the linear regression. 17.2 The linearity of the standard curve should cover the entire standard range. 17.3 The content MVOCs of a given volatile organics of the target analyte (µg/ cigarette) is determined from he calculated rel tive response ratio for the test portion, the slope and intercept obtained from the appropriate calibration curve, and the equation: where: MVOCs = calculated content, in µg/cigarette V = volume of extraction solution (10 ml or 20 mL) N = 1 (number of cigarette smoked onto each cartridge). RF = Relative response ratio m = intercept of the Y-axis of the calibration curve k = slope of the calibration curve Alternative calculation procedures may be used if applicable. 18. SPECIAL PRECAUTIONS After installing a new colum , condition it as specified by the manufacturer by injecting a tobacco sample extract under the specified instrument conditions. Injections should be repeated until the peak areas (or heights) of each of the volatile organics and the internal standards are reproducible. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 24 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 19. DATA REPORTING 19.1 Report individual measurements for each of the samples evaluated. 19.2 Report results as specified by method specifications. 19.3 For more information, see WHO TobLabNet SOP 02 [2.7]. 20. QUALITY CONTROL 20.1 Control parameters Note: If the control me surements ar outside th tolerance limits of the expected values, appropriate investigation and action must be taken. Note: Additional laboratory quality assurance procedures should be carried out in compliance with the policies of the individual laboratory. 20.2 Laboratory reagent blank To detect potential contamination during sample preparation and analysis, include a laboratory reagent blank, as described in [16.2.3]. The blank consists of all reagents and materials used in analysing test samples, including the extraction of CX-572 and glass fibre filter pad, and is analysed like a test sample. The assessment of the blank should be less than the limit of detection. 20.3 Quality control sampl To verify the consistency f the entir analy ical process, analyse a reference cigarette in accordance with the practices of the individual laboratory. 20.4 Additional QC Additional QC samples may be added as consistent with laboratory policy. 21. METHOD PERFORMANCE SPECIFICATIONS 21.2 Limit of Report (LOR) The LOR is set to the lowest concentration of the calibration standards used, recalculated to ng/cigarette (0.05 µmol/mL as the lowest calibration solution). 21.2 Laboratory fortified matrix recovery Recovery of analyte spiked onto the matrix is used as a surrogate measure of accuracy. Recovery is determined by spiking known amounts of standards (after smoking) and extracting by the same method as used for samples. Unspiked samples are also analysed. The recovery is calculated from the following formula and as shown in Table 5 below: World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 25 Recovery = 100 × (analytical result – unspiked result/spiked amount) Table 5. Mean and recovery spiked onto the matrix (to be added after the completion of the validation) Benzene 1,3-butadiene Spiked amount (µg) Mean (mg) Recovery (%) Spiked amount (µg) Mean (mg) Recovery (%) 16.9 18.4 108.9 10 9.4 94.0 33.8 37.0 109.5 20 18.6 93.0 67.6 75.2 111.2 40 41.9 104.8 21.4 Analytical specificity GC-MS provides excellent analytical specificity. The retention time, the confirmation ion ratio, an established range of ratios of the response of the quantification ion to that of the confirmation ion and quality control samples are used to verify the specificity of the results for an unknown sample. 21.5 Linearity The volatile organics calibration curves established are linear over the standard concentration range of 0.5–200 ng/mL. 21.6 Possible interference There are no known components that can cause an interference by having both a similar retention time and confirmation ion pair ratio as volatile organics or the internal standards. 22. REPEATABILITY AND REPRODUCIBILITY An international collaborative study conducted from 2015–2017, involving 10 laboratories and five samples (three reference cigarettes and two commercial brands), performed according to WHO TobLabNet SOP 02 (2.7) gave the following precision limits for this method. The difference between two single results found on matched cigarette samples by the same operator using the same apparatus within the shortest feasible time interval will exceed the repeatability, r, on average not more than once in 20 cases in the normal and correct operation of the method. Single results on matched cigarette samples reported by two laboratories will differ by more than the reproducibility, R, on average not more than once in 20 cases in the normal and correct operation of the method. The test results were analysed statistically in accordance with ISO 5725-1 [2.10] and ISO 5725-2 [2.5] to give the precision data shown in Tables 6–7. For the purpose of calculating r and R, one test result under ISO smoking conditions was defined as the average of seven individual replicates of the mean yield of three smoke traps (one cigarette smoked per smoke trap) from linear smoking machines and World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 26 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions three smoke traps for rot ry smoking machines. Under i tense smoking conditions, one test result was defined as the average of seven individual replicates of the mean yield of three smoke traps fr m li ear smoking machines and three smoke traps for rotary smoking machines. For mor information, see reference [2.6]. Table 6a and 6b. Precision limits for determination of 1,3-butadiene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette 1,3-butadiene: ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 11.06 1.96 4.27 3R4F 9 39.23 7.20 16.34 CM6 6 60. 6 1.74 2.18 Commercial Brand I 8 72.71 8.03 42.79 Commercial Brand II 8 61.58 9.97 16.80 Reference cigarette 1,3-butadiene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 7 82.26 8.11 8.63 3R4F 8 92.22 11.51 13.18 CM6 7 106.20 12.59 12.67 Commercial Brand I 8 153.96 17.20 70.04 Commercial Brand II 6 141.52 11.00 14.55 Table 7a and 7b. Precision limits for determination of Benzene (µg/cigarette) in mainstream cigarette smoke of the reference test pieces. Reference cigarette benzen : ISO smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 9 13.47 2.54 6.46 3R4F 9 44.50 6.94 10.15 CM6 8 72.86 5.94 11.40 Commercial Brand I 9 58.78 6.54 15.18 Commercial Brand II 9 49.94 8.83 15.37 Reference cigarette benzene: Intense smoking regimen, µg/cigarette N mcig rlimit Rlimit 1R5F 8 85.59 8.17 16.68 3R4F 9 95.95 8.49 40.92 CM6 8 108.35 6.93 23.52 Commercial Brand I 8 122.00 7.21 48.76 Commercial Brand II 8 111.77 6.60 36.32 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 27 Appendix 1. Typical chromatograms obtained in the determination of volatile organics in mainstream cigarette smoke Fig. A1. Representative chromatogram of standard 21 Total ion chromatogram of a mixed standard solution. BD, 1,3-butadiene; BZ- d6, benzene-d6; BZ, benzene Fig. A2. Representative chromatogram of volatile organics in cigarette mainstream smoke2 Total ion chromatogram of a sample solution. BD, 1,3-butadiene; BZ-d6, benzene-d6; BZ, benzene 1 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. 2 Derived from an international collaborative study conducted in 2012 and provided by the National Institute of Public Health, Japan together with Centers for Disease Control and Prevention, China. For information only. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. 28 World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions Appendix 2: Smoking Plans The described smoking plans are based on five different samples (cigarettes brand/ types) and seven replicates per sample. If a different number of sa ples or replicates is needed the plans should be adjusted accordingly. Smoking plan for 20-port linear smoking machine (one cigarette per cartridge) D ay Port number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 A B C D E A B C D E A B C D E 2 D E A B C D E A B C D E A B C 3 B C C D E A B C D E A B D E A 4 E A B C D E A B C D E A B C D 5 C D E A B C D E A B C D E A B 6 D C B A E D C B A E D C B A E 7 C B A E D C B A E D C B A E D Smoking plan for rotary smoking machine (one cigarette per cartridge) Day Run Sample Day Run Sample Day Run Sample Day Run Sample World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) ii WHO Library Cataloguing-in-Publication Data Standard operating procedure for determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions. 1.Nitrosamine – analysis. 2.Tobacco – chemistry. 3.Smoke – analysis. 4.Consumer product safety. 5.Materials testing – methods.I.World Health Organization. ISBN 978 92 4 150666 3 (NLM classifi cation:QV 137) © World Health Organization 2014 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. World Health Organization Tobacco Laboratory Network SOP 03 Determination of tobacco-specifi c nitrosamines in mainstream tobacco smoke 1 T o b a c c o F r e e I n i t i a t i v e T o b a c c o L a b o r a t o r y N e t w o r k ( T o b L a b N e t ) No.: SOP 03 Date: June 2014 World Health Organization Tobacco Laboratory Network Standard operating procedure for method Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Method: Determination of tobacco-specifi c nitrosamines in mainstream cigarette smoke under ISO and intense smoking conditions Analytes: 3-(1-Nitrosopyrrolidin-2-yl)pyridine(CAS# 16543-55-8) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (CAS# 64091-91-4) N-Nitrosoanatabine (CAS# 71267-22-6) N-Nitrosoanabasine (CAS# 37620-20-5) Matrix: Tobacco cigarette mainstream smoke particulate matter Last update: June 2014 World Health Organization Tobacco Laboratory Network SOP 09 Standard operating procedure for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions 29 1 1 A 3 31 B 5 61 C 7 91 C 2 A 32 B 62 C 92 C 3 A 33 B 63 C 93 C 4 B 34 C 64 D 94 B 5 B 35 C 65 D 95 B 6 B 36 C 66 D 96 B 7 C 37 D 67 E 97 A 8 C 38 D 68 E 98 A 9 C 39 D 69 E 99 A 10 D 40 E 70 A 100 E 11 D 41 E 71 A 101 E 12 D 42 E 72 A 102 E 13 E 43 A 73 B 103 D 14 E 44 A 74 B 104 D 15 E 45 A 75 B 105 D 2 16 D 4 46 E 6 76 D 17 D 47 E 77 D 18 D 48 E 78 D 19 E 49 A 79 C 20 E 50 A 80 C 21 E 51 A 81 C 22 A 52 B 82 B 23 A 53 B 83 B 24 A 54 B 84 B 25 B 55 C 85 A 26 B 56 C 86 A 27 B 57 C 87 A 28 C 58 D 88 E 29 C 59 D 89 E 30 C 60 D 90 E This document was prepared by members of the World Health Organization (WHO) Tobacco Laboratory Network (TobLabNet) as an analytical method standard operating procedure (SOP) for determination of volatile organics in mainstream cigarette smoke under ISO and intense smoking conditions.